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Frequency selectivity is one of the most important functions of the mammalian hearing 
organ – the cochlea. The interaction of fluid mass and organ of Corti compliance sets a traveling 
wave along the basilar membrane (BM), which is longitudinally tuned to different frequencies. 
Beyond this passive tuning process, cochlear amplification locally enhances the vibration of the 
best frequency peak by factors of hundreds to boost the frequency selectivity and sensitivity of the 
cochlea. This amplification is achieved by a positive feedback loop between BM motion and outer 
hair cell (OHC) electrical-mechanical response. However, this active mechanism is vulnerable to 
damage and cannot be fully recovered in vivo. As the instruments of cochlear amplification, the 
frequency response of BM and OHCs are of great importance to understand cochlear tuning 
process. This thesis used animal models, aimed to understand cochlear tuning and investigate 
possibilities to manipulate the cochlear amplifier, by testing the cochlear amplifier’s sensitivity to 
operating conditions. 
The first project tested whether the cochlear amplification can adjust to a lower 
endocochlear potential (EP), which controls OHC electromechanical force by providing part of the 
voltage source to drive OHC transduction current. To investigate this possibility, we use 
intraperitoneal (IP) and intravenous (IV) injection of furosemide to reversibly reduce EP, while 
monitoring the EP and cochlear amplification simultaneously. Cochlear amplification was 
monitored by measuring the local cochlear microphonic (LCM) and distortion product emission 
  
(DPOAE). With IV injection, the cochlear amplification observed in LCM could attain nearly full 
or even full recovery with reduced EP. This showed the cochlea has an ability to adjust to 
diminished operating condition. Furthermore, the cochlear amplifier and EP recovered with 
different time courses: cochlear amplification just started to recover after the EP was nearly fully 
recovered and stabilized. Using a Boltzmann model and the 2nd harmonic of the LCM to estimate 
the mechanoelectric transducer channel operating point, we found that the recovery of cochlear 
amplification occurred with re-centering of the operating point. 
The second project studied the physiological and anatomical effects of perfusing the 
cochlea with a viscous fluid, for better understanding cochlear fluid mechanics. Perilymphatic 
perfusion was applied with artificial perilymph and viscous sodium hyaluronate (Healon, HA) in 
four different concentrations. Using compound action potential (CAP) thresholds as an indicator 
of cochlear condition, our results and analysis indicated that the cochlea can sustain, without a 
significant CAP threshold shift, up to a 1.5 Pa shear stress. Histology of the cochleae perfused with 
higher shear stress showed the Reissner's membrane was torn. These data also indicated that the 
cochlea mechanics remains normal within increased perilymphatic fluid viscosity up to an increase 
of a factor of 50. Beside these findings, a temporary CAP threshold shift was observed, perhaps 
due to the presence and then clearance of viscous fluid within the cochlea, or to a temporary 
position shift of the organ of Corti. 
The last project was to test the effect of OHC intracellular Cl- concentration on cochlear 
amplification. Chloride is known to enable the electromotility of the OHC by binding its motor 
protein, prestin. By locally perfusing high chloride perilymph and the chloride ionophore 
tributyltin, this study investigated whether increasing intracellular chloride concentration can 
restore cochlear sensitivity in a cochlea that was slightly damaged. This had been shown by others 
  
in guinea pig.  However, we did not observe recovery in several attempts in gerbil, and did not 
pursue this study.   
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Chapter 1 Background and Significance 
The mammalian auditory system is capable of detecting and analyzing sounds over wide 
ranges of frequency and intensity. Humans can detect sound frequencies ranging from 20 to 20,000 
Hz. The threshold of human hearing is 2×10−5 Pa. A normal rock concert can reach up to 20 Pa, 
which is ~ 106 times larger than the pressure at hearing threshold. Due to such a large intensity 
range, the intensity of sound (p) is commonly expressed in logarithmic scale, defined as: 
 𝐿𝑝 = 20 𝑙𝑜𝑔10(𝑝/𝑝0) 𝑑𝐵 𝑆𝑃𝐿 (1.1) 
Where p0 = 2×10
−5 Pa. In the ear, the sound is detected, amplified, transmitted into 
nanoscale signal, and therefore interpreted by a delicate auditory system with mechanical and 
electrical signals involved.  
1.1 Auditory system 
Hearing in the mammal is a complex sense involving both the ear's ability to detect sounds 
in the environment and the brain's ability to interpret the sounds, for example, of speech. The sound 
waves from the air enter the ear, and are transmitted through three components of the auditory 
system: the outer, middle and inner ear (Figure 1.1).  
The primary role of the outer ear is to collect and guide the sound waves into the auditory 
sensory system. At the outer edge of the hearing system, the pinna surrounds the ear canal, 
functioning as a sound collector. The shape of its special cartilage structure and its facing direction 
provide information that helps the brain interpret the direction of the incoming sound source. From 
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the pinna, sound waves enter a tube-shaped tunnel, called the ear canal, and propagate to the end. 
The area difference between the pinna and ear canal gives rise to the first stage of sound signal 
amplification. Reaching the end of the ear canal, the sound strikes the eardrum (or tympanic 
membrane), causing it to vibrate. This vibration is then transmitted to the middle ear with high 
fidelity (1). Therefore, the acoustic compression wave in air is converted into mechanical vibration.  
 
Figure 1.1 Schematic of human auditory system. (Adapted from Didier Descouens Didier Descouens, licensed 
under a Creative Commons Attribution-ShareAlike 4.0 International License <https://creativecommons.org/ 
licenses/by-sa/4.0/>) 
The middle ear is composed of three ossicles within an air cavity called the tympanic cavity. 
This cavity is segregated from the outside by the eardrum, but connected with the larynx through 
the Eustachian tube, allowing the cavity pressure to equalize. The three ossicles are the malleus, 
incus, and stapes. The malleus connects to the eardrum, gathering the mechanical vibration 
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converted from the sound wave. The incus and malleus form a lever, providing a second stage of 
sound signal amplification. The stapes, the innermost bone of the middle ear, transfers mechanical 
energy to the inner ear through the oval window. The area difference between the eardrum and 
stapes provides another stage of pressure amplification. In gerbil, the middle ear forward 
transmission provides  20 - 25 dB pressure gain (2) with a flat frequency response through  40 kHz 
and ~25-30 μs group delay. 
At the end of the middle ear, the inner ear is connected via the stapes. The inner ear consists 
of two components: the cochlea and the vestibular system. The main function of the vestibular 
system is to sense the balance and spatial orientation of the animal. It is composed of two 
components: the three semicircular canals, which identify rotational movements; and the otolithic 
organs, the saccule and utricle, which identify linear accelerations. This information is then sent 
to neural structures for controlling eye movements, and to the muscles for keeping the upright 
posture for animals. The cochlea is the auditory component of the inner ear. It is a snail-shaped 
bony tube coiling 2-3 turns, functioning as a mechanical frequency analyzer. As the stapes vibrates 
in and out, it delivers sound pressure to the fluid in the three cochlear chambers, stimulating the 
sensory cells of the cochlea. These sensory cells convert the mechanical signal to graded electrical 
responses. The sensory cells are connected via chemical synapses to auditory neurons, where 
neural spikes are generated. The sound information travels via these coded neural spikes to the 
brain via the auditory nerve. 
1.2 The cochlea 
The cochlea, with a 35 mm length coiled into a volume of only 5 mm in diameter (in 
human), is responsible for the perception of the sound induced vibration. Beyond simply coding 
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the mechanical signal to a neural signal, the cochlea sorts the sound along its length by frequency, 
and contains a cell-based active mechanism known as the cochlear amplifier, that boosts its 
frequency resolution and intensity range.  
1.2.1 Anatomy 
 
Figure 1.2 A. Cross section of gerbil cochlea. B. Section of OC with labeled details. (SV: Scala vestibule, SM: 
Scala media, OC: Organ of Corti, TM: Tectorial membrane). (Adapted from Elizabeth S. Olson with 
permission) 
The cochlea is a snail-shaped bony tube (Figure 1.2 A). The central axis is called the 
modiolus. Inside the modiolus are the spiral ganglion and auditory nerve, which connect to the 
central auditory system. The cochlea is divided into three fluid-filled chambers: scala vestibuli 
(SV), scala media (SM) and scala tympani (ST). These three chambers are arranged in parallel and 
coiled in the shape of a snail. SV and SM are divided by Reissner’s membrane, which is simply 
composed of two cell layers: epithelial and mesothelial. SM and ST are divided by the basilar 
membrane (BM) and parts of the spiral lamina. SV and ST are connected at the apex of the cochlea 
through a narrow opening called the helicotrema, and at the base, terminate at two different 
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openings. SV ends at the oval window, where the middle-ear-transmitted sound pressure enters 
the cochlea via stapes vibration. ST ends at the RW, which is covered by a flexible membrane 
named round window membrane (RMW) maintaining the fluid in the cochlea while allowing the 
fluid to move.  
The BM, which separates SM and ST, is a membrane composed of fiber-embedded 
extracellular matrix material. It is supported by the osseous spiral lamina, a bony shelf projecting 
from the modiolus. The geometrical and mechanical properties of the BM vary along the cochlea: 
in the base, the BM is narrow, thick and stiff, while gradually becoming wider, thinner and more 
compliant towards the apex. These longitudinal variations result in a different resonant frequency 
along the BM: higher frequencies resonate near the base, and lower frequencies resonate near the 
apex. A recent study showed that the osseous spiral lamina in human is longer and more compliant 
than in rodents, and vibrates substantially with the BM, contributing to the cochlear partition 
stiffness (3).  
A matrix of cells, named the organ of Corti (OC), is attached to the top of the BM, (Figure 
1.2 B). The complex of BM, tectorial membrane (TM) and OC is named the organ of Corti complex 
(OCC). The OC contains sensory and supporting cells, functioning as the main sensory tissue of 
the cochlea. The supporting cells form a scaffolding that can withstand mechanical stress, to hold 
the basic structure of the OC. The sensory cells are responsible for sensing the motion of the BM 
and OC. There are two types of sensory cells (hair cells), the IHCs and OHCs. Radially, the IHC 
and OHC are separated by pillar cells. IHCs are set closer to the modiolus in one row, and OHCs 
are set at the lateral side in three rows. At the apical end of each hair cell, a bundle of stereocilia, 
known as a hair bundle (HB), protrudes from a rigid, flat circular plate at the top of the cell body. 
These stiff stereocilia (Figure 1.3) are arranged in parallel rows with an increasing length medial-
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to-lateral. An extracellular filament called a tip link connects adjacent stereocilia (Figure 1.3 C), 
with one end attached to the gate of the mechano-electrical transduction (MET) channel on the top 
of the shorter stereocilia while the other end attaches the next taller one. On the top of the hair cells 
overlays an acellular gel called the TM. The BM motion converts to a relative radial motion 
between TM and RL at the top of hair cells. This relative motion deflects the HB, opening and 
closing the MET channels, leading to a transduction current to stimulate the hair cells.  
 
Figure 1.3 A. Mouse OC from the top view, with TM removed. Green arcs are the stereocilia on top of the 
hair cells. One row of IHCs and three rows of OHCs are surrounded by the supporting cells (blue and red). 
(Adapted from Elizabeth Carroll Driver, licensed under a Creative Commons Public Domain Mark 1.0 License 
<https://creativecommons.org/licenses/PDM/1.0/>) B&C. SEM images of stereocilia bundles on OHC (B) and 
IHC (C) of wild type mice. (Adapted from Hertzano et al. (4), licensed under a Creative Commons Attribution 
2.5 Generic License <https://creativecommons.org/licenses/by/2.0/>)  
While sharing a similar structure, the IHC and OHC differ substantially in both shape and 
function. IHCs are flask-shaped with a centrally placed nucleus (Figure 1.2 B), with a mild “U” 
shaped HB (Figure 1.3 A&C) that protrudes towards but is not attached to the TM. The deflection 
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of the IHC HB is achieved through fluid coupling. In response to BM mechanical vibration, the 
IHCs release neurotransmitter, triggering action potentials in afferent fibers connected with the 
IHC basal surface. OHCs are cylindrical cells, with the nucleus placed more basally than in IHCs 
(Figure 1.2 B).  The OHC length increases from base to apex. The stereocilia HB of OHCs are “W” 
shaped (Figure 1.3 A&B), and the longest row of stereocilia directly connects to the TM. The 
relative motion between TM and RL directly deflects the HB. OHCs are believed to be the 
instrument of amplification within the cochlea, which actively enhances the frequency selectivity 
and sensitivity of the cochlea by electrical-mechanical generated forces. OHCs are connected to 
both afferent and efferent fibers, but predominantly efferent nerve fibers. The human cochlea 
contains ~ 3,500 IHCs and 12,000 OHCs. 
As noted above, the cochlea is structurally separated into three chambers by RM and BM, 
but the fluid has its own boundaries, which are different from the mechanical boundaries (Figure 
1.4 A). The fluid system of the cochlea is mainly divided into two. SV and ST are connected 
through the helicotrema and therefore share the same fluid, a high-sodium low-potassium solution 
called perilymph. The SM is filled with endolymph, which contains a high concentration of 
potassium. The perilymph and endolymph are separated by tight junctions of RM and the top 
surface of the sensory and supporting cells, the reticular lamina (RL). Therefore, the cell bodies of 
the sensory and supporting cells are bathed in perilymph from ST, while the stereocilia of the hair 
cells are bathed in endolymph.  
The potassium gradient between perilymph and endolymph is generated by active secretion 
of K+, accompanying a high potential about +80 mV at the SM, known as endocochlear potential 
(EP). This EP varies slightly along the cochlea. Normally, the EP is higher at the base, and lower 
at the apex (5, 6). The EP is generated within the stria vascularis (7) inside the SM lateral wall 
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(Figure 1.4 B). The stria vascularis has one layer of marginal cells, and one layer composed of 
intermediate and basal cells. Between the two layers is an intrastrial space, which exhibits a high 
potential (+90 mV) and a low K+ concentration (7-10). The formation of EP is still under debate, 
but the two-pump model is the most well accepted (7, 11-13). Active transport by the K+ ion pumps 
(Na+, K+-ATPase and NKCC) at the basolateral membrane of the marginal cells maintains a low 
[K+] in intrastrial space, which enables K+ to diffuse from intermediate and basal cells through 
Kir4.1 channels. This high K+ conductance of the apical membrane of the intermediate cells creates 
a +90 mV potential in intrastrial fluid, and results in +80 mV EP in endolymph after a 10 mV 
decrease across marginal cells. 
Cochlear perfusion of the cochlear perilymphatic space is a useful technique to alter the 
fluid within the cochlea. Since the first use of inner ear perfusion (14), cochlear perfusion 
technique has gradually matured and is now regularly used in research. To improve controlling 
parameters in cochlear perfusions, Nuttall et al. (15) provided data about the influence of pH, 
temperature and dissolved oxygen gas concentration of the perfusate. (16) developed a stable 
intracochlear infusion technique with micro-cannula and osmotic pump for rodents that enabled 
both chronic and acute intracochlear perfusions while maintaining hearing. Different kinds of fluid, 
or even bubbles (17) have been applied in cochlear perfusion for a variety of purposes. The 
objectives of these studies included assessing ototoxicity of drugs (18), understanding properties 
of cochlear fluid (19, 20), or investigating cochlear mechanics by controlling the extracellular 




Figure 1.4 A. Fluid distribution in the cochlea. Perilymph and endolymph are seperated by RM and the tight 
junctions at the top of the OC. The shaded area shows the endolyphatic space. B. Enlargement of the box 
region in A showing the ion-transport apparatus for EP formation. (NKCC: Na+, K+, 2Cl−-cotransporter, TJ: 
tight junction). 
1.2.2 Passive cochlear mechanics 
The mechanical motion of the BM is essential for stimulating the sensory hair cells. The 
description of cochlea mechanics was first reported by Von Békésy in the 1940s (22), when he 
observed traveling waves in post-mortem human cochleae. As the stapes vibrates in and out, it 
delivers sound pressure to the fluid in the cochlear chambers. The BM is then driven to move by 
the pressure of those fluids. As a result, this interaction between fluids and BM sets a traveling 
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wave along the BM. The BM is a frequency selective membrane, whose mechanics are dominated 
by a stiffness that decreases from base to apex (23). The amplitude of the travelling wave reaches 
its maximum approaching a certain location of the BM that resonates to the frequency of the 
incoming sound. The frequency for which BM motion peaks is known as the best frequency (BF) 
(or characteristic frequency (CF)) of the location. As the BM mechanics is dominated by the 
longitudinally decreasing stiffness noted above, the CF decreases from base to apex. This 
frequency tuning process forms a tonotopic map that can be expressed by an empirical equation 
(24, 25): 
 𝐶𝐹 = 𝐴(10𝛼𝑥 − 𝑘) (1.2) 
x is the distance or distance proportion from the apex on BM. A, α, and k are species-
dependent constants (for gerbils, A = 0.4, α = 2.1, k = 0.85, when CF is expressed in kHz and x is 
fractional distance from the apex (varying from 0 to 1).  
 
Figure 1.5 “Uncoiled” cochlear diagram. The cochlea is modeled as a long box with two chambers. SM is 
simplified as a thin BM. The sound pressure enters via pressure on stapes, setting a traveling wave along the 
BM in positive x direction. 
Many mathematical models were built based on the theory of passive cochlear mechanics. 
Classical models simplify the cochlea as an “uncoiled” fluid-filled long box (Figure 1.5) with two 
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chambers, the SV and ST, with symmetric dimension. The detailed structure of cochlea is 
neglected. The BM is typically treated as a set of transverse beams, or as an isotropic or orthotropic 
plate. In all cases its mechanical impedance varies with longitudinal distance. Sound stimuli enter 
the modeled cochlea via pressure on the stapes, setting a traveling wave along BM. The pressure 
in SV and ST are assumed equal and opposite. To simplify, the fluid in the cochlea (perilymph) is 
assumed to be inviscid and incompressible. Under these assumptions, a simple 2-d cochlear model 
stimulated with pure-tone pressure stimulation can be built. The pressure along z = 0 expressed as: 
 𝑃𝑧𝑜(𝑥) = 𝑃𝑧𝑜(0)𝑒
−𝜔𝜌2 ∫ 𝑌(𝑥′)𝑑𝑥′
𝑥










𝜔 ) + 𝑟(𝑥)]
 
(1.4) 
Z(x) is the mechanical impedance of the BM. m, s, and r are the mass, stiffness, and 
resistance of the BM per unit area. x is the distance from stapes. ρ is the fluid density. ω is the 
angular velocity of the stimulus. A simulation with 2 dyne/cm2 pressure at the stapes is shown in 
Figure 1.6.  
This 2-d model reproduced the traveling wave Von Békésy observed. As the wave 
propagates from the base approaching its resonant place, it slows down as its wavelength decreases. 
The phase of the pressure and velocity accumulates more and more rapidly. The wavelength would 
ultimately reach zero if the wave reached its resonant place, therefore the wave is extinguished 
beforehand (26). As the wave approaching towards the BF place, the pressure decreases as the 
resistance exponentially increase, and the velocity increases as the stiffness decreases. At the BF 
place, the velocity reaches its maximum. After that, the wave is extinguished, and the phase 
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reaches a plateau. Higher frequencies peak closer to the base of the cochlea. In this simple 2-d 
model, the higher frequencies peak with a faster and larger accumulated phase.  
 
Figure 1.6 2-D model of passive cochlea mechanics demonstrating traveling wave along the cochlea. Left 
panel: Pressure wave; Right panel: Velocity wave. x is the distance from stapes. Stimulus with three 
frequencies are shown (dotted: 0.5 kHz, dashed: 2 kHz, solid: 4 kHz). Higher frequency peaks near the base 
of the cochlea, and lower frequency peaks near the apex. (m = .01 g/cm2 (assume m is unchanging in x), s = 
2×108 e(-1.5x) dynes/cm3, r = 5 e(2.25x) dynes/cm3.) 
In most models, the fluid is considered to be inviscid to reduce the computational 
complexity. In reality the cochlear fluids, perilymph in SV and ST, and endolymph in SM have a 
viscosity similar to water (27). The traveling wave in the cochlea is based on fluid inertia and OCC 
stiffness, and if the fluid in the cochlea becomes substantially more viscous, the cochlea’s 
mechanical response and wave pattern will change. Studies on cochlear models showed that an 
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increase in fluid viscosity led to a decrease in BM motion and the longitudinal width of the 
envelope of the traveling wave (28), and flattened the tuning curves (29). In another model fluid 
viscosity was necessary to suppress standing waves (30). Wang et al. (31) predicted that a change 
in fluid viscosity by a factor of two up or down had only a small effect on the power output of the 
OHCs.  Thus, there was theoretical interest and study on the question of the effect of fluid viscosity 
on cochlear mechanics, but experimental data were lacking.  
Besides the traveling wave included by the simplified model, there are other transmission 
modes in the cochlea as result of asymmetric physical and geometrical properties of the cochlea: 
1. the compression/rarefaction mode in phase with the stapes plunging motion, distributed 
uniformly in the cochlea, and 2. evanescent modes that exist near stapes and RW, decay rapidly 
towards the apex (25, 32-34). Those two modes are in phase with the stapes motion without delay, 
thus they are “fast” compare to the “slow” traveling wave. Most models ignored the fast modes 
because the slow wave is the primary mode of hair cell activation. Fast modes are only able to 
excite the hair cells at high SPLs, and the pivoting motion of stereocilia is ~10 times smaller than 
the excitation of the slow mode (35, 36). However, the fast modes appear in experiments and have 
been recorded in animals in the supra-BF region where the slow traveling wave has died off, as 
the BM displacement scaled linearly in different SPLs, and was in phase with the stapes motion 
(25, 37-39). 
1.2.3 Active cochlear mechanics 
The passive mechanics of cochlear frequency analysis, which is purely based in the 
mechanical properties of the cochlea fails to explain much experimental data in the live animal. 
For example, the passive model cannot explain why sounds with extremely low sound pressure 
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produce motions that are large enough to be heard. Later, a local mechanical amplification process 
was proposed. One experimental clue to this process was published by Kemp (40), where the 
existence of evoked otoacoustic emissions (OAE) was described. These faint sounds, recorded 
coming out of ears in response to clicks, suggested that the cochlea generates energy itself during 
its transduction processes. This mechanism, that some parts of the cochlea actively enhance 
hearing function, was then discovered and named cochlear amplification (or the cochlear 
amplifier). The process of cochlear amplification enhances cochlear sensitivity at low sound levels 
in its BF, sharpening the frequency selectivity and sensitivity of the cochlea. 
 
Figure 1.7 ST pressure measured in gerbil in vivo (solid line) and post-mortem (dashed line) with 30–90 dB 
SPL stimuli. A: Pressure amplitude in dB SPL. B: Pressure refrenced relative to ear canal (EC) pressure.  
Cochlear amplification of factor of ~ 50 showed at lower SPL in vivo near BF = 23 kHz. (Data from (41), with 
permission.) 
Cochlear amplification can be detected only in live animals. Figure 1.7 shows a 
measurement of intracochlear ST pressure close to basal BM in vivo and 10 min post-mortem (41). 
The BF of the measured place was 23 kHz. When post-mortem, the pressure scaled linearly with 
SPL (Figure 1.7 A dashed line), and the amplitude gains were similar when normalized by ear 
canal (EC) pressure (Figure 1.7 B dashed line). Under in vivo condition, near the BF, the 
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normalized pressure and voltage (Figure 1.7 A&B solid line) showed larger amplitudes at smaller 
SPLs, indicating a stronger cochlear amplification at lower SPL. At the other frequencies, their 
amplitudes were similar and scaled linearly with SPL. The cochlea amplification is more nonlinear 
and sharply tuned in the base than the apex (42-44). 
OHCs are believed to be the cellular origin of amplification, which was confirmed by 
several experimental results, including that the loss of OHCs, either by noise damage or by 
chemical ablation, caused threshold shifts and changes in auditory nerve turning curves (45-48). 
Afterwards, studies of isolated OHCs with voltage clamp technique demonstrated its voltage-
dependent length change, named electromotility, which was then believed to be the cellular basis 
of the cochlear amplifier (49, 50). This hypothesis was further supported by in vivo experiments 
with manipulation of OHC driving current (51, 52). Cochlear amplification is achieved by a 
positive feedback loop between the BM motion and OHC electrical response (illustrated in Figure 
1.8). The transverse vibration of BM creates a shear motion between TM and RL that deflects the 
OHC HB in the radial direction. This radial motion stretches/compresses the tip links, thus 
opens/closes the spring-gated MET channels. A transducer current then flows into the OHC soma 
from the HB from the high K+ endolymph. These processes transduce mechanical BM motion to 
electrical OHC transduction current. Responding to the change in OHC membrane potential, the 
motor protein of OHC, prestin, changes between short and long states, thus changing the length of 
OHC. This movement provides electro-mechanical feedback that actively increases the BM 
motion. The OHC transduction current scales linearly with BM displacement for small 
displacements, and saturates at large BM displacement. As a result, cochlear amplification is 
stronger (relative to the input) at lower sound pressure levels. With an electrode close to the BM, 
extracellular OHC voltage can be detected which is proportional to the transduction current. This 
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is termed the local cochlear microphonic (LCM). The LCM is generated by local OHC responses, 
thus is a useful tool to detect cochlear amplification. 
 
Figure 1.8 Schematic of OHC micromechanics at the rest state (A&C) and stimulated state (B&D). A and B: 
cross section of OC. C and D: hair bundle with MET channel labeled. When the BM moves upward, the shear 
motion between TM and RL deflects the OHC HBs, opening the MET channels on top of the stereocilia. The 
current goes through the MET channels and therefore depolarizes the OHC soma, causing it to contract.  
In order to amplify the BM motion, the input of OHC somatic force should be phase-locked 
in a cycle-by-cycle manner. The in vivo experimental data showed clear evidence that the cochlear 
amplifier is BF specific. How this tuning of the cochlear amplifier happens is still under debate 
since the electromotility of the mammalian OHC showed no intrinsic filtering (53, 54), and the 
OHC generates forces over wide frequencies (55-60). In this case, a “second-filter” other than the 
traveling wave has been predicted to activate the local cochlear amplification. TM resonance is 
one of the most popular candidates (55, 61-65). In 2013, Dong and Olson (41) observed a phase 
shift in OHC-generated voltage relative to displacement starting from ~ 0.76 CF. At higher 
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frequencies, the voltage led the BM displacement by ~ ¼ cycle, indicating a positive power 
injection of OHC somatic force. They hypothesized that this phase shift gave rise to the onset of 
cochlear amplification. In a followed-up study (66) with a physiologically based 3D cochlear 
model, this phase shift was shown to be determined by the frequency response of the TM radial 
impedance. With correct TM radial resonance frequency, the phase shift was able to be reproduced 
by the model. Those findings provide evidence that TM resonance plays an important role for 
cochlear amplifier activation. 
1.2.4 Hair cell basics 
 Mechanoelectrical process 
The forward transduction of the hair cells with low frequency stimulus (to keep the 
description simpler) can be described by the Davis model (Figure 1.9) (67). In this model, the hair 
cell is modeled as a static soma resistance (Rbas) in series with a variable HB conductance (Gap+Δ
G), which is tightly coupled to the mechanical input through MET channels. The potential 
difference between positive EP (EEP) and negative hair cell resting potential (EOHC or EIHC) drives 
cationic transduction current, primarily K+ but Ca2+ is also important.  The IHC holds a resting 
potential at -40 mV, and OHC at ~ -60 mV. 
EP is essential for cochlear amplification, by providing part of the voltage source needed 
to drive OHC transducer current, which leads to OHC electromechanical force. Many studies have 
investigated how the EP affects hearing function. The EP can be manipulated through several 
methods, including direct current injection to SM, stria vascularis dysfunction by aging, or loop 
diuretic drugs (i.e. furosemide, ethacrynic acid, bumetanide). Animal models showed significant 
decline in hearing function under low EP, including linearization of BM velocity responses, and 
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decrease in auditory nerve (AN), compound action potential (CAP), cochlear microphonic (CM) 
and distortion product otoacoustic emission (DPOAE) responses (51, 68-71). However, the EP 
modifies cochlear amplification in several ways, beyond simply reducing the driving force for HC 
current. Quasi-static current across the OC was shown to be able to modify BM motion (72, 73), 
and even geometry (68). Reducing EP can shift the operating point (OP) of the OHC MET 
transduction channel (74, 75). The necessity of EP for cochlear amplification was also challenged 
by an early study, where the DPOAEs recovered before a reversibly reduced EP, indicating that 
cochlear amplification may be able to adjust to a new, lower EP (69).  This previous study provided 
part of the motivation for our experiments involving furosemide and EP reduction.   
 
Figure 1.9 Davis model of hair cell transduction current for low frequency stimulus. Transduction current is 
powered by the EP (EEP) and negative hair cell resting potential (EOHC or EIHC). Deflection of stereocillia cause 
a change in HB conductance (Gap+ΔG). RSM and RST represent the resistances of SM and ST. 
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The MET channel on the hair bundle is a spring-gated, non-specific cation channel. [Ca2+]  
in the endolymph was found to be crucial to maintain MET channel functioning (76). The 
transduction currents display a Ca2+-driven adaptation. The MET channel has at least two states, 
with its open probability determined by HB deflection. At the resting state, the transduction 
channel has an open probability ~ 0.5 (77), provide a resting transduction current through the hair 
cells. The balancing of the inward current and outward voltage-dependent K+ current results in the 
hair cell resting potential. With two states, the MET channel open probability (P0) is modeled as a 
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uhb/rl is HB deflection relative to the RL. X0 is a constant displacement that represents uhb/rl 
at the resting state, equivalent to the operating point (OP) of the transduction curve. fgs is the single 
channel gating force. kB is the Boltzmann constant, T is the temperature, and γ is a geometrical 
gain factor. This open probability is proportional to the transduction current, and thus the receptor 
potential. 
To maximize the IO slope and thus output amplitude, the OP on the MET channel 
transduction curve should be centered. For OHCs, which act primarily as alternating current (AC) 
effectors, the intracellular recordings showed responses that are reasonably, but not precisely 
centered. For IHC, where a direct current (DC) response is important for transmitter release, the 
MET channel is expected to be uncentered and that expectation has been born out experimentally 
(79-81). The extracellular receptor potentials can be measured with an electrode on the RW. The 
periodic AC portion called CM is mostly contributed by the OHC receptor currents at the basal 
cochlea (82-84). When measured close to the BM, extracellular OHC voltage, which is 
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proportional to the extracellular current from hair cells close to the electrode, can be measured and 
exhibits cochlear amplification (41). At the base of the cochlea, the primary source of the DC 
portion of the gross extracellular receptor potentials, named the summating potential (SP), is 
dominated by the basal IHCs. In the other turns, this conclusion is still under debate, and both hair 
cell types appear to contributing to the SP (82-84). 
 
Figure 1.10 Transduction curve of IHC and OHC. The IHC operates away from the center of the transduction 
curve, and the stimulus generates a large DC response for transmitter release. The OHC operates near the 
center, and the stimulus generates a nearly symmetrical response. The response saturates at high stimulus 
levels. 
 Electromechanical process of the OHC 
OHC electromotility introduced in Section 1.2.3 was first observed in 1985 by Brownell et 
al. (49). In this voltage-dependent movement, hyperpolarization of an OHC led to an expanded 
state of the cell soma, and depolarization led to a compact state. The OHC static length change is 
~ 2 – 15 nm/mV in isolated OHCs (85), but in the more constrained in-vivo state, the OHC length 
change is expected to be reduced. 
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This relationship is somewhat analogous to a gating charge movement known from 
voltage-gated ion channels where, under the influence of an electric field, charged amino acids 
(gating charge) clustered in the S4 helix move towards the outside or inside of the membrane, 
opening or closing the ion channel. The voltage-dependent gating charge movement could be 
regarded as a change in capacitance (C = dQ/dV, where Q is the gating charge, and V is the 
membrane potential), and it is added to the inherent linear capacitance of the cell. In OHCs, the 
charge movement arises from the charged moiety of a protein, the motor protein in the basolateral 
membrane. Therefore, the OHC motility could be detected by the change in capacitance, which 
was termed “nonlinear capacitance” (NLC). OHC NLC shows a bell-shaped dependence on 
membrane potential (Figure 1.11). It reflects the probability of the motor protein being transformed 
between states, i.e. the probability of moveable charge being translocated to different positions. At 
the maximum NLC (Vm = Vpkcm = -60 mV), the moveable charge is most likely to move between 
different states, and the electromotility of the cell is maximum; while at smaller NLC (Vm close to 
+/-150 mV), the moveable charge is more likely to stay at a certain state, and the cell shows less 
electromotility. 
 
Figure 1.11 Modeled NLC using two-state Boltzmann function (Vpkcm = -60 mV). 
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Prestin, the motor protein for OHC, was identified in 2000 by Zheng et al. (86). This motor 
protein arranges in an array at the lateral membrane of OHC to generate motility. It behaves as a 
biological piezoelectric element comprising at least two functional domains: the voltage sensor 
detects the change of membrane potential, and the actuator undergoes a conformational change. 
Unlike most ion channels, the OHC motility could not be eliminated by neutralizing cations or 
external anions; however, it was found that NLC was reversibly eliminated by removing Cl- ions 
from the cytoplasm of cells (87). On the basis of this result, Cl- binds to prestin to enable its 
electromotility. Two models have been proposed demonstrating the conformational change of the 
prestin after binding chloride ions (Figure 1.12). In the intrinsic voltage sensor model, the chloride 
ion binds allosterically with the prestin, enabling its form change. The voltage sensing results from 
the movement of intrinsically charged amino acid residues. Some data are consistent with an 
extrinsic voltage sensor model, which regards prestin as a dysfunctional anion transporter. In this 
case the bound Cl- is the voltage sensor. (88, 89).  
 
Figure 1.12 Two models illustrating prestin as a motor protein after binding chloride ions. Left: intrinsic 
voltage sensor model. Right: Extrinsic voltage sensor model. 
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The OHC electromotility is driven by receptor potential but independent of transmembrane 
current (90). Experiments controlling the receptor potential showed that OHC somatic motility has 
a high frequency cut off (corresponding to the frequency where there is a 3 dB drop in amplitude) 
to at least 50 kHz, and the isometric force is constant up to at least 70 kHz (91, 92). However, 
since the receptor potential is expected to be attenuated in vivo by the low-pass filter induced by 
OHC membrane capacitance, it was under debate that whether OHC somatic force can provide 
enough force for cochlear amplification at high frequencies. In 1990s, the cutoff frequency of OHC 
membrane was believed to be < 1 kHz (54, 93), which is far less than the normal hearing range. 
Recently, several explanations have been proposed regarding this question. Johnson et al. (94) 
suggested that the OHC exhibits a higher resting potential in vivo, activating more ionic channels, 
which reduces the RC time constant of the cell membrane. Mistrik et al. (95) argued that the 
tonotopic variation of the OHC membrane conductance lowers the attenuation of transmembrane 
potential in higher frequencies, resulted in only -5 dB per decade in the range of 0.2 – 30 kHz. 
This relatively slight attenuation was further supported by other physiological models, proving 
that even with a low cutoff frequency, somatic motility is strong enough and necessary for the 
power generation of the cochlear amplifier to operate at high frequencies (96, 97). However, 
further experimentation is needed to fully understand the basis of the cochlear amplification. 
1.2.5 Cochlea as a nonlinear system 
The cochlea is a nonlinear system involving four potentially significant nonlinearities: the 
geometry of HB deflection, the MET transduction process, the transduction from current through 
OHC basolateral membrane to OHC receptor potential, and the nonlinear electromotility of the 
prestin. It has been experimentally shown that the nonlinearity of the OHC MET channel is the 
dominant nonlinearity in the system (98). A Boltzmann function like Eq. (1.5) can be used to 
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describe the relationship between stimulus pressure and LCM (74, 75, 99). This forms a sigmoid 
shape as in Figure 1.13 (upper left): transduction is approximately linear at low stimulus levels 
and saturates at high stimulus levels.  
 
Figure 1.13 Modeled OHC transduction curve and LCM response with pure tone stimulus.  LCM waveforms 
of three SPLs are shown (dotted, dashed, solid lines corespond to 55, 65 and 75 dB SPL). LCM spectrum is 
the FFT of 75 dB SPL response. Operating point alteration away from 0 generates even order harmonics in 
OHC transduction. 
With a centered OP, the MET channel would operate in a relatively linear region of the 
transduction curve. Then, with a sinusoidal input that is not too large, the output will be nearly 
sinusoidal. If the OP is shifted, the LCM waveform will become asymmetrically distorted. Because 
the distortion is asymmetric, it is an even-order distortion and even harmonics will emerge in the 
spectrum of the LCM waveform. When the stimulus is large enough to reach the saturated region, 
the LCM waveform will become symmetrically distorted. In this case, odd harmonics will be 
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generated  (75, 100-102). Based on mathematics, for a local nonlinearity, the phase of the 2nd, 3rd 
harmonics is either zero or half a cycle relative to the fundamental. These relationships have been 
previously described and supported experimentally in low frequency CM measurements at the 
cochlear base (74, 75). Animal models showed that various factors can shift the OP of the OHC 
MET transduction curve, for example, endolymphatic hydrops caused by noise exposure, SM 
pressure change, and EP alteration induced by direct current injection, ototoxic drugs, hypoxia or 
anoxia (74, 75, 99, 103).  
 
Figure 1.14 Schematic shows DPOAE generation and recording. A. 2f1-f2 nonlinear distortion originally 
generated at f1 and f2 traveling wave overlap region. The energy travels basal to EC and apical to its own 
characteristic frequency (CFDP) at the BM. The later then reflects back to the EC. The DPOAE is a vector 
summation of the two sources (104, 105). B&C. Frequency spectrum examples (gerbil) of two-tone response, 
measured at the EC (B) and f2 best place (C). The distortions are generated with an inte rval of f2-f1. 
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When a healthy cochlea is stimulated by two pure tones, distortion products (DP) will be 
generated (Figure 1.14 A). Two single tones (assume f1 and f2) with comparable amplitudes 
generate distortions spaced by f2-f1 (Figure 1.14 C). This distortion exists not only in the 
intracochlear mechanical and electrical response – the energy spreads and travels back to the EC 
in a detectable level, known as distortion product otoacoustic emission (DPOAE) (Figure 1.14 B). 
The measurement of DPOAE is a quick and non-invasive tool, used to gauge the cochlear amplifier 
experimentally and clinically. Specially, the 2f1-f2 DPOAE is named as “cubic distortion product”, 
and is relatively large in gerbils.  
1.3 Motivation 
By 2015, over 5% of the world’s population (360 million people) had disabling hearing 
loss. More than 90% of this hearing loss occurs when hair cells or auditory nerve cells are damaged 
or destroyed. The cochlea is a delicate organ that is vulnerable to damage. When damage alters 
mechanics or driving voltage (EP), cochlear amplification can be lost or diminished. OHCs and 
other functional organs (like stria vascularis) could be damaged because of aging (presbycusis), 
noise exposure, or ototoxic drugs, while other components of the ear still remain functional. In 
these cases, the sensitivity and frequency resolution of the cochlea would decrease due to the 
absence or reduction of cochlear amplification. Once hair cells are injured or destroyed, they can 
never be replaced in mammals. Hearing aids can help these patients in some degree, but still have 
limitations. Hearing aids mainly increase the sound level, which could increase cochlear sensitivity 
but could not increase its frequency resolution. To date, there is no medical instrument that helps 
repair the cochlear frequency resolution. Exploring the regulation mechanism and possible 
manipulations of the cochlear amplifier is of great importance. 
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As the instruments of cochlear amplification, the frequency response of BM and OHCs are 
of great importance to understand cochlear tuning. To understand cochlear tuning and investigate 
possibilities to manipulate the cochlear amplifier, we measured BM, OHC and neural responses, 
with experimental manipulations. 
Aim 1: Determine if the cochlear amplifier can adjust to low EP 
Age-related strial degeneration and subsequent EP decline is a common form of 
presbycusis, resulting in cochlear amplification loss. Studies suggested that cochlear amplification 
may be able to adjust to a lower EP, opening the question of whether a high EP is necessary for a 
moderate degree of cochlear amplification. We hypothesize that this adjustment could be achieved 
by changing the MET operating point (OP). To test this hypothesis, we used furosemide to reduce 
EP reversibly, and directly measured local OHC-generated voltage (known as LCM) and DPOAE, 
to compare the time-scale recovery of EP, the cochlear amplification, and the OP of the OHC MET 
channel. Executing this aim was the primary achievement of this thesis work.  
Aim 2: Determine the maximum viscosity of cochlea perfusate that does not perturb cochlear 
operation 
This study was focused on the physiological and anatomical effects of perfusing the 
cochlea with a viscous fluid. The initial aim was to find a suitable viscosity for perfusion-based 
cochlear implant implementation (106), and the study also advanced our understanding of cochlear 
fluid mechanics. This aim was achieved by in vivo perilymphatic perfusion of viscous sodium 
hyaluronate (Healon, HA) at different concentrations to raise the viscosity, with CAP thresholds 
measurement used to gauge the cochlear condition. Executing this aim was a secondary 
achievement of this thesis work.   
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Aim 3: Test if cochlear amplification can be enhanced by augmenting chloride concentration 
Chloride is important to OHC electromotility. Cl- binds to the motor protein prestin, 
densely packed in the OHC basolateral membrane, to enable prestin’s voltage-dependent 
conformational change. Theoretically, a higher intracellular chloride concentration in OHCs may 
activate more prestin. By locally perfusing high chloride perilymph and chloride ionophore TBT, 
this study investigated whether increasing intracellular chloride concentration can boost cochlear 






Chapter 2 Experimental design and methods 
In this thesis, the Mongolian Gerbil, Meriones unguiculatus, was used as the animal model. 
The gerbil is a mammal in the order Rodentia, related to mice and rats, with an average weigh 
about 71 g. They have a hearing range of 0.2–50 kHz, relatively lower than mice and rats and thus 
more comparable to human. Their cochleae are relatively large and easy to access. Those features 
make gerbils a good animal model for hearing research. The aim of the thesis is to better understand 
cochlear amplification; thus the research was focused on the basal turn of the cochlea that shows 
a larger cochlear amplification.  The basal turn is also relatively experimentally accessible.   
This section introduces common experimental methods, while the specific methods will be 
described in each chapter separately.  
2.1 Animal preparation 
Animal procedures were approved by the Institutional Animal Care and Use Committee 
(IACUC) of Columbia University. Adult gerbils with normal CAP response (method will be 
discussed in Section 2.3) were used in the experiments. Animals were weighed, sedated with 
ketamine (0.03 mL) and anesthetized with pentobarbital (40–60 mg/kg, diluted to 10 mg/mL).  
Supplemental dosing was applied (~10 mg/kg per 20 min) throughout the experiment depending 
on the animal’s anesthesia level, checked by toe pinch. Lidocaine gel was used if local anesthesia 
was needed. 0.5 ml of warm saline was administered every 2 hrs, and buprenorphine (2 mL/kg) 
was given every six hours as an analgesic. Body temperature was monitored and maintained 
around 37 °C by a thermostatically controlled heating pad. After the pinna was removed, the 
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animal was placed in a supine position and with its head glued to a stable head holder. A 
tracheotomy was performed to maintain a clear airway. The bulla was then opened to expose the 
cochlea (the view showed in Figure 2.1 red circle). At the end of the experiment, the animals were 
overdosed to achieve euthanasia.  
2.2 Acoustic system 
The sound stimulation and data acquisition was performed by a Tucker-Davis 
Technologies (TDT) system controlled by MATLB interface. The sampling rate of the TDT D/A 
and A/D system can reach up to ~ 260 kHz, enabling high frequency measurements. The animal 
surgery and measurement were performed in a sound booth, to reduce the noise introduced by the 
environment.  
 
Figure 2.1 System block diagram. The experiment was done in a sound booth. The animal was placed in a 
supine position with the cochlea exposed (red circle). Stimuli generation and data acquisition was performed 
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by computer controlled TDT system. The DC and AC signals were collected via different routes, picked up 
by microelectrode or metal electrode.  
Sound stimulation was generated by a TDT system driving a Radio Shack dynamic speaker, 
connected in a closed-field configuration to the EC. The speaker was shielded in a solid aluminum 
box and grounded to reduce electromagnetic pick-up by the measurement system. The calibration 
of sound was performed within the EC using a Sokolich ultrasonic probe microphone before each 
experiment to ensure accurate pressure levels were delivered. The microphone signal was collected 
by the RX6 microprocessor via channel 1 (CH1). The Sokolich microphone has a flat frequency 
response from 0.1 – 65 kHz, with approximately ideal linear phase delay. The microphone output 
goes positive for negative pressure and this 180 offset was corrected in the presented data. Pure 
tones of a single frequency or two frequencies were applied to measure cochlear responses. For 
single tone and two tones, responses were measured at a ~ 200 kHz sampling rate for ~ 1 s and divided 
into 51 segments. The first segment was ignored to avoid transients in the system, and the remaining 
50 repetitions were then averaged to reduce the noise. The stimulation and averaging methodology 
for CAP measurement are different and will be discussed in Section 2.3. 
The AC and DC signals were measured via different routes such that the AC signal can be 
monitored continuously. In this thesis, the AC signal includes electrocochleography (especially 
CAP) and LCM. Those AC signals were picked up using metal electrodes with flat frequency 
response up to at least 80 kHz to achieve a broad-band measurement. The signal was then filtered 
and pre-amplified, and collected by the RX6 microprocessor via channel 2 (CH2). The two 
channels of RX6 were synchronized internally. The DC signal refers to EP. It was measured by 
glass microelectrode connected to an Ag-Ag/Cl pellet that maintains a steady potential. After 
filtering and pre-amplifying, the signal was digitized and directly collected into the computer. This 
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method enables us to continuously monitor the EP variation while performing different tests for 
AC signals. The detailed methods will be discussed in following sections.  
2.3 Electrocochleography 
When measured at RW, three extracellular receptor potential can be detected (Figure 2.2): 
CAP, CM and SP. CAP represents the summed response of the firing of AN fibers, and therefore 
is a quick method to gauge the cochlear condition. It starts with a prominent notch (N1) and a peak 
(P1). The threshold of CAP response is defined by the difference between N1 and P1 amplitudes 
reaching a certain "threshold" value. The CM is a periodic AC portion of the gross signal, with the 
same frequency as the stimuli. It is mostly contributed by the OHC receptor currents at the basal 
cochlea (82-84). The SP is a DC signal, dominated by the asymmetric receptor potential of the 
basal IHCs (83, 84).  
 
Figure 2.2 Example of electrocochleography. With a pure tone stimulus, the gross signal (A) is the summation 
of: CAP (B), generated by AN fiber; CM (C), sinusoid signal mainly produced by the basal OHCs; and SP 
(D), DC signal generated from the asymmetric response of hair cells.  
In this thesis, CAP thresholds were measured to gauge cochlear condition. A silver wire 
electrode was placed on the bony round window to measure the CAP response. The reference 
electrode was inserted into the muscle of the jaw, and the gerbil body was grounded. An AC 
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amplifier with a first order high pass filter and a second order low pass filter, with a pass band of 
~ 200 Hz – 4 kHz, was used to measure the CAP response. However, the SP may not be fully 
eliminated after the band pass filter, because onset/offset of the SP can pass through. The CAP 
stimulus was composed of a 3 ms tone pip of variable frequency presented every 12 ms, with 
alternating polarity to eliminate the phase-locked CM from the averaged responses. CAP responses 
were collected for 16 frequencies ranging from 0.5 kHz to 40 kHz. Thresholds were determined 
by eye as ~ 3V peak-to-peak responses. 
2.4 DPOAE 
 
Figure 2.3 Example spectra with 65 dB SPL two-tone stimulus (expt696). A. Ear canal pressure. B. LCM. 
This figure is very similar to that in our published paper (107).   
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DPOAE is generated by the cochlear nonlinearity, and is a quick and easy method to 
monitor the condition of cochlear amplification. It can be measured directly from the EC analyzed 
using Fourier analysis. A two-tone stimulus with fixed frequency ratio f2/f1 = 1.25 and equal 
stimulus levels (55 and 65 dB SPLs) was applied as in our previous studies (41, 108). The 
amplitude of the cubic distortion tone (2f1-f2) DPOAE was calculated using the FFT of the EC 
pressure measurement. With the same stimulus, LCM DP was measured simultaneously via the 
LCM electrode. Figure 2.3 shows an example of ECP and LCM spectra with a two-tone stimulus 





Chapter 3 Adaptation of cochlear 
amplification to low endocochlear potential 
3.1 Introduction 
EP is essential for cochlear amplification (67). It provides part of the voltage source needed 
to drive OHC transducer current, which leads to OHC electromechanical force. Beyond simply 
reducing the driving force for HC current, EP reduction will also reduce the silent current flowing 
through the cochlea, thus might affect cochlear amplification in several ways.  
Age-related strial degeneration and subsequent EP decline is a common cause of 
presbycusis (109-111), resulting in loss of cochlear amplification. As an ototoxic drug to mimic 
strial degeneration, furosemide is a loop diuretic whose primarily affect is on the stria vascularis 
(13, 75) and reversibly decreases EP (69, 70, 112-114). The recovery takes minutes to hours, 
depending on the dosage and method of delivery, and gives us a tool to trace the variation in 
cochlear function with varying EP. Ruggero and Rich (51) used IV injection of furosemide to 
change EP, and observed the abolishment and recovery of cochlear amplification by measuring 
the BM velocity at frequencies around the local BF after the injection (51). However, lacking a 
measurement of EP, it is unclear whether the EP and BM velocity nonlinearity recovered 
simultaneously.  DPOAE and EP were measured simultaneously by Mills et al. (69), with DPOAE 
used to noninvasively probe active cochlear mechanics and amplification (69). With an 
intraperitoneal (IP) injection of furosemide that reversibly reduced the EP, they found that 
DPOAEs recovered before EP. This indicated that cochlear amplification may be able to adjust to 
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a new, lower EP. This finding seems at odds with the findings of Sewell (70), where the EP and 
AN responses recovered in-step with each other. However, AN responses depend on both IHC and 
OHC, and OHC activity might be able to adjust to a change of EP, while AN responses are still 
low. The homeostatic system of cochlear amplification might be relatively robust.  
DPOAE represents OHC nonlinearity and is an indirect measure of cochlear amplification, 
thus the recovery of amplification with reduced EP hypothesized by Mills et al. (69) needs to be 
shown to be compelling. In addition, the mechanism for the recovery needs exploration. For 
example, reduced EP could alter the geometry of the OHC due to electromotility, leading to a static 
OP change of the MET channels (74, 75). We hypothesized that a recovery of cochlear 
amplification with low EP could occur by the OHC optimizing its OP to a more centered point on 
the IO function, compensating for the decreased EP. This centering process may not occur 
simultaneously with the EP recovery. With sinusoidal input, OP variations can be explored with 
harmonic analysis of the output. This analysis is guided by previous work by other groups, for 
example  Kirk and Patuzzi (101) and Sirjani et al. (75).  
In this study, furosemide was used to reversibly reduce EP, which was continuously 
monitored. The LCM, which represents OHC current, was directly measured simultaneously with 
EP and DPOAE, to investigate the adjustment process of cochlear amplification under reduced 
and recovering EP. The LCM exhibits traveling wave delay, sharp tuning at low and low-moderate 
stimulus levels, and nonlinearity in the peak region that is similar to that of BM motion and 
pressure at the BM (41, 115, 116). Thus, it serves as an appropriate measure of local cochlear 
amplification. Harmonics of LCM were measured to find OP variations. Our main findings were 
as follows. 1. With IP injection of furosemide we confirmed the Mills et al. result: DPOAEs (in 
the frequency range they studied) recovered fully while the EP was reduced. 2. The EP-dependent 
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changes of LCM (representing cochlear amplification) and DPOAE were different, thus DPOAE 
failed to accurately report the variation of cochlear amplification. 3. With intravenous (IV) 
injection of furosemide, cochlear amplification recovered over a different time course than EP, 
and was related to adjustment of the OP.  
This chapter is largely derived from the publication (107). 
3.2 Materials and Methods 
3.2.1 Acoustic stimulus and cochlear potentials measurement 
Two types of stimuli were applied: single-tone and two-tone. These two types of stimuli 
were applied alternatively to measure LCM and DPOAE/DP. Each of the sub-measurements took 
~ 4 min, for 8 min total. At the same time, EP was continuously monitored in every 1 sec.  
Single-tone stimuli were swept in steps of 0.5 or 1 kHz between 1 kHz and 40 kHz. 
Multiple stimulus levels were applied (30, 45, 65 and 85 dB SPL), to evaluate the nonlinearity of 
LCM. In one experiment (expt705), following an initial multi-frequency, multi-level run, a series 
of runs were made with just two frequencies (BF and BF/2) at multiple levels (30 to 90 dB SPL in 
step of 5 dB), in order to achieve finer time and level resolution. LCM was usually measured every 
8 min and was measured every 2 min in the experiment devised for finer time resolution that 
probed only two frequencies. The time points are defined when 65 dB SPL BF responses were 
measured, unless noted. 
For the two-tone experiments, two pure tones (f1 and f2) with equal level of 55 and 65 dB 
SPLs and fixed frequency ratio f2/f1 = 1.25 were applied. f2 frequencies were swept in steps of 
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0.5 or 1 kHz between 1 kHz and 40 kHz. The time points were defined when the 65 dB SPL BF 
response was measured, unless noted. 
CAP thresholds were measured before and after the ST cochleostomy to ensure a healthy 
starting cochlea (Figure 3.1). In three animals we measured CAP near the end of the experiment. 
Because EP did not fully recover following furosemide administration, the final CAP thresholds 
are expected to be elevated somewhat. Two of them (expt655&705) had only a small threshold 
change, and in general the change correlated with the final EP, as will be discussed later.  
 
Figure 3.1 CAP thresholds. Measured before (solid) and after cochleostomy (dotted) (n = 8), and at the end of 
the experiment (dash-dot) (n = 3). The CAP threshold elevations after cochleostomy were less than 5 dB. At 
the end of the experiment, two of three animals (expt655&705) showed small threshold changes. Because EP 
did not fully recover, some elevation is expected.  
3.2.2 LCM - measurement and basic analysis 
The LCM was measured using a tungsten microelectrode with ~ 1 µm tip diameter (FHC 
Inc. Bowdoin, ME). The electrodes showed a resistance of 0.3 – 1 M measured in saline with a 
500 Hz stimulus, and had a flat frequency response over the frequency range of the measurement 
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(change within 0.8 dB up to 80 kHz). The electrode was advanced into the cochlea through an 
~100 µm diameter hole, in the ST of the basal turn of the cochlea where the BF is 15 – 20 kHz 
(Figure 3.2 A&B). The electrodes were connected to an AC pre-amp (PARC EG&G) with gain of 
1000 and pass band of 0.3 – 300 kHz and the data were collected by the TDT system. To measure 
the local OHC response, the electrode was slowly advanced to be close to the BM, until the 
measured LCM was comparable to that observed in Dong and Olson (41), where the LCM was 
measured ~10 µm away from BM. At this point traveling wave delay was present in the phase, and 
the amplitude was sharply tuned at low SPL (Figure 3.2 D). In healthy preparations, the LCM 
showed a high degree of nonlinearity in the peak region, and at low SPL there was a sharp peak at 
what is by definition the BF. The LCM phase relative to EC at the BF was ~ 1 cycle. In less healthy 
cochleae, the peak was less prominent, and to be consistent, in the analysis to follow the BF of the 
measurements were determined by the frequency for which phase accumulated ~ 1 cycle. We 
compared the frequency tuning curve of an AN fiber (117) and LCM, and the sharpness of tuning 
was similar in the tip region (Figure 3.2 C). These observations support the expectation that LCM 
was generated primarily by local OHCs. Notches do occur, particularly at relatively high SPL, that 
are likely due to phase cancellation. This cancellation could be between local and non-local sources 
(41, 118) or between local fast and slow mode responses (32).  
The OHC MET transduction curve can be estimated using LCM measurements. 
Theoretically, the transduction curve can be continuously traced with a full CM response (74). 
This requires an electrode to be able to pick up stable DC as well as AC signal. The size of the 
electrode is also limited to maintain a healthy cochlear condition. For measuring response at lower 
frequencies, the best candidate is a glass electrode with an Ag/AgCl electrode. However, the 
measurement with glass electrode exhibits a low-pass feature and thus is unachievable in high 
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frequencies. With a metal electrode, the high frequency AC signal and its harmonics can be fully 
traced, but the DC signal will be missing. In this condition, the generated transduction curve is 
valid only when the DC is minimal, which corresponds to a centered OP.  (As an additional note, 
even with a glass electrode the DC measured might be an inaccurate measure of OHC responses, 
since the IHC contribution to DC is substantial.) 
 
Figure 3.2 A. Cross-sectional view of the cochlea, showing the placement of sensors. The LCM electrode was 
placed near the BM via a hole in the basal turn of ST. The EP electrode was placed to access the second turn 
of SM. B. Experimental photo. The green line shows division of basal and second turn of the cochlea. C. 
Comparison of frequency tuning of LCM and AN fiber with BF = 18 kHz (AN data from (117)). The threshold 
of LCM was 0.004 mV. D. Frequency response example of LCM fundamental with stimulus levels ranges 
from 30 – 90 dB SPL in 5 dB steps (expt705). At the BF of the preparation (18 kHz), the ampli tudes show a 
nonlinearity factor of ~ 250. The rapidly accumulating phase at 14 – 20 kHz shows traveling wave delay, 
affirming that the measurement was from local OHCs. This figure is very similar to that in our published paper 





Figure 3.3 Schematics showing the methodology for estimating OHC MET transduction curve. The signal was 
reconstructed with the fundamental, 2nd and 3rd harmonics of the raw signal (left). The maximum and 
minimum value of the reconstructed waveforms were found and fitted with a Boltzmann model to generate 
the OHC MET transduction curve (right). 
With a pure-tune stimulation, the LCM response is composed of the same frequency and 
its harmonics. Thus to clean the noise, the inverse Fourier transform method was applied. The 
waveforms of the response were reconstructed using the fundamental, 2nd and 3rd harmonics of 
the raw signal (Figure 3.3 left). The maximum and minimum value of the reconstructed waveforms 
were found, and plotted versus their stimulus levels to generate the transduction curve (plus signs 
in Figure 3.3 right). With 10 – 90 dB SPL stimuli in 5 dB SPL step, 34 pairs of data were generated. 
The data were then fit with a Boltzmann model (solid line in Figure 3.3 right) using a least-square-
fit (74, 75, 99): 
 
𝑉 = 𝑉𝑜𝑓𝑓 − 𝑉𝑠𝑎𝑡 +
2𝑉𝑠𝑎𝑡
1 + 𝑒𝑥𝑝 (𝑧 ∙ (𝑖𝑛𝑝𝑢𝑡 + 𝑂𝑃))
 
(3.1) 
Voff represents the vertical offset, Vsat represents the saturating voltage, and z is a sensitivity 
factor. OP is the operating point of this OHC transduction curve. This method follows that of 




The EP is a ~ 80 mV DC voltage that can be measured in SM. This potential difference 
between SM and the other scalae is vulnerable to small damage to the cochlea and frequently 
deteriorates during long measurements. There are two common approaches to measure EP in 
cochlea. The first approach is via the RW, pushing the electrode through ST until it breaks through 
the BM and enters the SM. This approach is feasible to measure the EP at the basal turn. However, 
although the tight connection between the BM and the electrode seals the gap between them, slow 
leakage between the perilymph and endolymph reduces the lifetime of the preparation. It also 
effects the normal functioning of the cochlea since part of the BM was torn. The second approach 
is via the lateral wall. With this approach, the EP is stable for a fairly long time as long as the SM 
hole is less than 10 µm diameter (in gerbil), minimizing the trauma to stria vascularis. This 
approach also leaves BM intact to keep the normal function of the cochlea. In this thesis, the second 
approach was used based on our experimental objective. 
The EP was measured simultaneously with LCM, via a hand-drilled ~10 µm diameter hole 
in the SM of the second turn of the cochlea (Figure 3.2 A&B). The reference electrode was placed 
on the muscle of the right leg, and the animal body was grounded. To measure this DC signal, for 
both working and reference electrodes, microelectrode holders (World Precision Instruments) with 
an Ag-Ag/Cl pellet were used. For the working electrode, a pulled glass micropipette with ~10 µm 
tip was connected to the pellet, filled with 0.5 M KCl as a fluid bridge to keep a stable potential. 
In the reference electrode, saline was used as a fluid bridge. The EP electrodes had a resistance of 
3 – 8 M when measured in saline. Just before inserting the EP electrode and again when removing 
it at the end of the experiment, we measured the voltage at the bony shell of the cochlea to give 
the 0 mV reference. The difference between these values, the reference drift, usually was less than 
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3 mV. If the drift exceeded 3 mV, we corrected the EP by a value found by assuming that the 
reference voltage had drifted linearly with time. After a pre-amp with a gain of 10, the measured 
DC voltage was continuously collected every second with a DATAQ DI-710 Data Acquisition & 
Logger device, and sent to the computer as discussed in Section 2.2. 
3.2.4 Ototoxic drug 
Furosemide (Salix Injection 5%, Madison, NJ) was used to reversibly reduce EP, 
administrated either intraperitoneal (IP) or intravenous (IV). To repeat the Mills et al. study (69), 
120 mg/kg furosemide was injected IP. IV injection was performed via the femoral vein of the left 
leg, at a dose of 100 mg/kg. The injections were performed at t = 0 min in the reported results. 
3.3 Results 
3.3.1 DPOAE could recover fully, while EP and LCM remained subnormal after 
furosemide IP injection 
In the first set of experiments, 120 mg/kg furosemide was administrated IP. Figure 3.4 A 
(n = 2, shown in 2 different colors) compares the time variations of the simultaneously measured 
EP, LCM (65 dB SPL) and 2f1-f2 DPOAE (65 dB). As shown in the top of Figure 3.4 A, after IP 
furosemide was administered, EP decreased quickly, reached its minimum within 20 – 30 min, 
rapidly recovered between 30 and 50 min, and slowly recovered over ~ 150 min. The time course 
varied somewhat between animals. The EP never fully recovered in our preparations, and lack of 
full EP recovery following furosemide is common in the literature (69, 70, 113, 114). Figure 3.4 
A bottom shows DPOAE variations at two frequencies: near the BF (while avoiding DPOAE 
notches that might be due to the interference from multiple distortion sources (105)), and 8 kHz to 
repeat the Mills et al. study (69). The DPOAE fully recovered at 30 – 50 min, while EP remained 
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depressed. The DPOAE sometimes even overshot the initial values. These findings were similar 
to those of Mills et al., which are included in Figure 3.4 A (red curves in EP/DPOAE variations). 
LCM variations are shown in the middle of Figure 3.4 A. Unlike DPOAE, the LCM variations 
were more similar to EP: they did not reach a full recovery. Thus, the recovery of DPOAE failed 
to reflect a true recovery of cochlear function.  
 
Figure 3.4 Cochlear responses after 120 mg/kg furosemide IP injection at 0 min. LCM amplitudes of the 
fundamental frequency are shown. A) Variations of EP, LCM at BF (expt644: 16 kHz, expt652: 10 kHz were 
shown instead of BF = 13 kHz to avoid a notch that might be due to phase cancellation (41, 118)), and 2f1-f2 
DPOAE near f2 = BF (expt644: f2 =16 kHz, expt652: f2 = 14 kHz) and at f2 = 8 kHz. LCM and DPOAE are 
in dB referenced to their initial values. (See Figure 3.5 for fuller DPOAE frequencies.) Red lines are results 
from Mills et al. (69) applying 100 mg/kg IP injection in gerbil. B&C) EP and LCM (at BF) variations of two 
animals (B: expt644 and C: expt652). LCM with 45, 65 and 85 dB SPL stimulus levels are shown. Red stars 
in B indicate the corresponding times for the frequency responses in D. LCM gain normalized by ECP. D) 
LCM frequency responses from one experiment (expt644) at -13, 26, 50 and 150 min after furosemide 
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injection. The green dashed line at 100 is a guide for the eye, to compare the magnitude at the different times. 
LCM gain and phase were normalized by ECP.  
Figure 3.4 D (expt644) shows the detailed frequency response of LCM measured -13 (the 
minus sign means times before the injection), 26, 50 and 150 min after furosemide injection. The 
corresponding EP time-course is in Figure 3.4 B, and the superimposed red stars indicate the 
measurement times of Figure 3.4 D. At -13 min, before the furosemide injection, the LCM showed 
cochlear amplification tuned at the BF of ~ 16 kHz. The rapid phase accumulation observed at 15 
– 20 kHz indicates that we were detecting traveling wave responses, which shows that our LCM 
measurement is dominated by the responses of local OHCs. Along with the EP drop after 
furosemide injection, the amplitude of LCM at 26 min decreased significantly and nonlinear 
compression was absent from 30 – 65 dB SPL. The 85 dB SPL response retained nonlinearity 
following furosemide, likely because the OHC transduction mechanism was nearly saturated – this 
can be considered “passive nonlinearity”. After that, EP and LCM slowly recovered, and stabilized 
at ~ 150 min. The bottom panel of Figure 3.4 D at 150 min shows the frequency response when 
the EP had stabilized. The LCM shows substantial recovery, but has not returned fully to its initial 
condition.  
Figure 3.4 B (expt644) and C (expt652) show the time course of normalized LCM with the 
BF stimulus at 45, 65 and 85 dB SPL. In the EP recovery phase, a two-stage recovery of the LCM 
response was observed. In the first stage (25 min ~ 40 min), the LCM amplitude increased 
significantly, but the nonlinear compression was still small, except for the “passive nonlinearity” 
at 85 dB SPL. In the second stage (40 ~ 60 min), the recovery of response amplitudes slowed, but 
the mid-SPL “active” nonlinear compression recovered significantly – the orange and yellow lines 
in the lower panels of Figure 3.4 B&C diverged from each other. The two-stage recovery can also 
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be seen in Figure 3.4 D, where at 26 minutes all the SPL curves have dropped well beneath the 
1mV/Pa line, at 50 minutes they are back up at the line, and at 150 minutes the mid-SPL responses 
have begun separating, sharpening the lower SPL responses. 
 
Figure 3.5 DPOAE (2f1-f2) and LCM DP (2f1-f2) change in full frequency range after 120 mg/kg furosemide 
IP injection at 0 min. Sound stimuli 55 and 65 dB SPL. expt644. DPOAE and LCM DP fully recovered at ~ 
50 min. and could overshoot initial values. A – D: DPOAE, E – H: LCM DP (BF=16000 DP=9600). 
Amplitudes are in dB SPL for DPOAE, and dB Volts for DP. dB changes (C, D, G, H) were referenced to 
their values before furosemide injection. The closed triangles indicate the DPOAE frequency that corresponds 




The mesh plots in Figure 3.5 show how the 2f1-f2 DPOAE and DP changed in time 
following furosemide through the full frequency range (f2 = 1 – 40 kHz, in 1 kHz steps). This 
figure illustrates the wide frequency range for which DPOAE and DP fully recovered, and in some 
cases even overshooting initial values, in the absence of full EP recovery (Figure 3.4 A, top). A – 
D show DPOAE and E – H show the LCM DP. Results from one experiment are shown (expt644) 
for clarity; results from other experiments were similar. Each horizontal row represents DPOAE 
or LCM DP amplitudes at a specific time after the furosemide injection. The amplitudes are color-
coded in dB SPL or dB Volts (Figure 3.5 A, B, and E, F) and also in dB change relative to their 
initial values (Figure 3.5 C, D, and G, H). Before the furosemide injection, all DPOAE amplitudes 
started at a healthily high level throughout the frequency range. With the gradual recovery of EP, 
DPOAE amplitudes almost fully recovered for 2f1-f2  17 kHz, which is equivalent to f1  23 
kHz and f2  28 kHz. At some frequencies, DPOAE overshot its original values (change > 0 dB). 
High frequencies recovered more slowly and did not attain their initial levels. The LCM DP shows 
a similar time variation as the DPOAE, and also shows overshooting compared to initial values.  
3.3.2 Changes with IV injection of furosemide 
 
Figure 3.6 EP change after 100 mg/kg IV furosemide injection (n=5). Faster decrease and recovery in EP were 
observed compare to IP injection (Figure 3.4 A).  
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To attain a fuller EP recovery, furosemide was administered IV (100 mg/kg), for which 
both reduction and recovery of EP are known to occur relatively quickly compared to IP (69, 113, 
114, 119). Figure 3.6 shows the summary of EP change after IV furosemide injection. The EP 
dropped below 0 mV within just a few minutes, and stabilized ~ 50 min after furosemide was 
administrated. In most of the animals, EP recovered to 50 – 60 mV in 50 min. Among all the 
experiments, expt696 showed the fullest recovery, thus the full set of data will be shown with this 
animal, accompanied with data from several other animals to demonstrate repeatability.  
 DPOAE variation after IV furosemide injection 
The mesh plots in Figure 3.7 show the change of the 2f1-f2 DPOAE in time across a wide 
frequency range. Results from two animals (A – D: expt696, E – H: expt718) are shown, with 55 
and 65 dB SPL stimuli. Similar to Figure 3.5, the amplitude variations are shown in dB SPL (A, 
B and E, F) and in dB change relative to their initial values (C, D and G, H). Both preparations 
show a DPOAE decrease just after furosemide injection, and a rapid partial recovery at ~ 20 min 
that was sometimes transient, with a more robust recovery starting at ~ 80 min. Expt718 showed 
a fuller recovery, with nearly full recovery at low frequencies (2f1-f2 < 8 kHz). But unlike with IP 
injection, where the DPOAE fully recovered and even overshot at 2f1-f2 < 17 kHz, in general 
DPOAE did not recover fully with IV injection. Some of the DPOAE results observed at 10 – 13 
kHz in Figure 3.7 are likely due to disturbance caused by the proximity of the LCM electrode to 
the BM. This proximity apparently caused reductions in the initial DPOAE, especially when f2 
was near the local BF (indicated by filled triangles at bottom of plots). This disturbance was not 
observed in experiments with IP injection (Figure 3.5) possibly because the electrode was farther 
from the BM during the IP experiments. Closer proximity to the BM in the IV experiments is 
supported by the larger LCM (Figure 3.8 H – J) compared with the IP experiments (Figure 3.4 D). 
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The disturbance is unlikely due to damage, because the measured LCM showed a healthy 
amplitude and degree of nonlinearity, and the cochlear amplifier was functioning prior to IV 
furosemide, and recovered. Furthermore, the initial DPOAE reductions observed at 10 – 13 kHz 
were not observed in the LCM DP responses, as will be shown later (Figure 3.14). In contrast, in 
a previous study of DPOAE and local ST pressure following localized damage, a significant 
reduction of DPOAE, local DP and cochlear amplification occurred when the BM was damaged 
by ~ 10 μm mechanical indentation (120).  
 
Figure 3.7 DPOAE (2f1-f2) change in full frequency range for two animals (A – D: expt696, E – H: expt718) 
after 100 mg/kg furosemide IV injection at 0 min. Unlike with IP injection, with IV injection, in general 
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DPOAE did not recover fully. Amplitudes are in dB SPL.  dB changes (C, D, G, H) were referenced to their 
initial values before furosemide injection. The closed triangles indicate the DPOAE frequency corresponding 
to f2 = LCM measurement BF, and the open triangles indicate f1 = LCM measurement BF.  
 Cochlear amplification recovered more slowly than EP 
 
Figure 3.8 EP and LCM variation following 100 mg/kg furosemide IV injection in three animals. LCM 
amplitudes of the fundamental frequency are shown. A–C) EP variation. Red star shows the times that 
frequency responses (H–J) were measured. D–F) LCM variation in response to 30, 45, 65 and 85 dB SPL 
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stimuli at the local BF. (SPL key is in H.) Amplitude, normalized by ECP. The BFs are noted on the right 
bottom corner of panels D – F. H – J) The amplitude and phase of LCM relative to ECP, measured before and 
multiple times after the furosemide injection. The green dashed line at 100 is a guide for the eye, to compare 
the magnitude at the different times. Furosemide was injected at 0 min. See H for the color legend. Data lower 
than noise level (~1×10 -4 mV = -80 dBV) were excluded. 
Figure 3.8 shows EP and LCM variations for three animals (A, D, H: expt696; B, E, I: 
expt670; C, F, J: expt718). Figure 3.8 A – C show EP variation with furosemide IV injection at 0 
min. Figure 3.8 D – F show LCM amplitude variation in time at the BF, with stimulus levels of 30, 
45, 65 and 85 dB SPL. Figure 3.8 H – J show the LCM frequency responses at different time points 
(labeled as red stars in Figure 3.8 A – C) before or after furosemide IV injection. Before furosemide 
injection, all three animals showed a significant degree of nonlinearity at their BF and rapid phase 
accumulation around BF frequencies (Figure 3.8 H – J first row). Similar to with IP injection 
(Figure 3.4 D), after furosemide was IV-injected, the EP dropped, the amplitude of the LCM 
decreased and nonlinear compression disappeared except at the highest SPL (Figure 3.8 H – J 
second row). The 30 dB SPL response showed a higher gain at lower frequencies (3 and 2 min 
points in expt696 and expt718) because the data were being collected during the time EP was 
rapidly dropping. The LCM and EP recovered with different time courses. At ~ 40 min, EP had 
recovered substantially, and the LCM amplitude had recovered to some degree, but nonlinear 
compression for low-mid SPL remained low (Figure 3.8 H – J third row). At this time EP stabilized, 
but LCM continued to recover (Figure 3.8 D – F). At ~100 min, the nonlinear compression and 
perhaps more importantly, tuning at low SPL was substantially or even fully recovered (Figure 3.8 
H – J fourth row). The LCM of expt718 took a longer time to recover (205 min). Its recovered 
amplitude was higher than its initial value. The phase excursion at high SPL was greater in the 
recovered preparation than initially, signifying that the traveling wave mode was being amplified, 
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and thus exceeded the fast mode through a wider frequency and SPL range (121). This latter 
observation applies to expt696 as well. We acknowledge the possibility that the electrode, starting 
very close to the BM, could come a few micrometers closer during the experiment, which could 
account for the observed supra-recovery of the LCM. The observation that cochlear amplification 
recovered later than the major, but incomplete EP recovery indicates the cochlear amplification 
recovery was not directly due to EP recovery. The LCM almost fully or even fully recovered even 
when EP was ~ 20 mV lower than its initial value. 
3.3.3 Simulation of harmonic behavior with sigmoidal OHC MET channel 
Due to the electromotility of OHC, reduced EP can alter the resting state of the OHC. 
Reduced EP will also affect the ionic composition of cochlear fluids and OHCs. MET channel 
mechanics are particularly sensitive to OHC [Ca2+] (76). Any of these could lead to a static OP 
change of the MET channels, and affect the harmonics of OHC transduction current and LCM. 
Harmonic analysis can be used to explore a shift in OHC transducer OP. In this section we use a 
Boltzmann model to simulate the relationship between harmonics and OP change, before showing 
the experimental harmonic analysis. 
The relationship between LCM and the input stimulus follows a 2-state Boltzmann function 
as stated in Eq. (3.1) (74, 75, 99). This forms a sigmoid shape as in Figure 3.9 A (solid line): 
transduction is nearly linear at low stimulus levels and saturates at high stimulus levels. The source 
of the data points in Figure 3.9 A will be described in Section 3.4.1.  
As mentioned in Section 1.2.5, with a centered OP, the MET channel would operate in a 
relatively linear region of the transduction curve (Figure 3.9 D). Then, with a sinusoidal input that 
is not too large, the output will be nearly sinusoidal (Figure 3.9 E). If the OP is shifted (Figure 3.9 
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F&H), the LCM waveform will become asymetrically distorted (Figure 3.9 G&I) and even 
harmonics will emerge in the spectrum of the LCM waveform (75, 100-102). When normalized 
by the fundamental, the 2nd harmonic amplitude plotted versus OP is V-shaped (Figure 3.9 B): 
the normalized 2nd harmonic is smallest when the OP is centered at 0, and larger when the OP 
moves away from zero. The phase difference between the 2nd harmonic and the fundamental is 
either zero or half a cycle (Figure 3.9 C). At negative OP, the phase difference is zero, showing 
that the fundamental and 2nd harmonic are in phase. At positive OP, the phase difference is a half 
cycle. 
 
Figure 3.9  Modeled LCM changes driven by OHC transduction OP change. A) OHC transduction curve based 
on 2-state Boltzmann model. Experimental data was from expt705 in response to 10 – 90 dB SPL 9 kHz stimuli 
8 min after furosemide injection (data shown in Figure 3.11 below). B) Model-predicted 2nd harmonics of 
LCM (referenced to fundamental amplitude) versus OP change. The amplitude change shows a V -shape that 
is steeper at higher stimulus levels (solid line: 65 dB SPL; dashed line: 75  dB SPL). C) Model-predicted phase 
of second harmonic relative to fundamental versus OP. Phase is right -angled line, large insets illustrate the 
meaning. The 2nd harmonic and the fundamental are either in phase (left side, phase difference of zero) or 
out of phase (right side, phase difference of  = 1/2 cycle) depending on whether the OP is negative or positive. 
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D – I) OHC transduction curve (D, F, H) and modeled LCM waveform with pure tone stimuli (E, G, I. solid 
line: 65 dB SPL; dashed line: 75 dB SPL) in three different OP cases (0, -0.3, and 0.3 Pa). At the stimulus 
level used for this illustration the LCM is approximately sinusoid when OP = 0 (E), and is distorted when OP 
moves away from 0 (G&I).  
3.3.4 2nd harmonic overshoot 
Here we describe the harmonics of the experimentally measured LCM. Figure 3.10 shows 
the 65 dB SPL LCM frequency response and its harmonics from expt696 with IV furosemide 
injection. Each color represents a measurement at a different time following furosemide injection. 
The phase of the fundamental (Figure 3.10 B) changed little after furosemide injection, and the 
plateau region that is dominated by a fast mode started above the BF, at ~ 20 kHz. Figure 3.10 C 
shows the 2nd harmonic amplitude. Prior to furosemide injection, a peak of the 2nd harmonic was 
apparent at a frequency close to BF/2. This peak might be due to “amplified distortion” that does 
not originate from the measurement location (122). This distortion is generated basal to the point 
of measurement, and then amplified by the cochlear amplifier as it travels to its own best place. 
After furosemide injection, the amplified distortion greatly diminished, and had still not recovered 
at 108 min (pink line). The lack of non-local distortion is important to the harmonic analysis, which 
assumes that the harmonics are primarily due to local nonlinearity. Further support for the locality 
of responses is from the response phase. The 2nd harmonic phase is plotted referenced to 2 times 
the phase of the fundamental (Figure 3.10 D). At frequencies below the plateau frequency above 
the BF (~ 20 kHz), the 2nd harmonic phase was generally half or full cycle relative to the 
fundamental, i.e., either in phase or out of phase, and was composed of nearly flat regions at those 
values, separated by sloping regions that occur along with local minima in the amplitude. As noted 
in Figure 3.9 C, half or full cycle is the expected harmonic phase for harmonics generated by a 
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nonlinear IO function, and variations from that behavior could indicate travel of the harmonic 
within the cochlea after generation. The observed amplitude and phase behavior give us confidence 
that the harmonic responses we measure are mainly locally generated.  
In Figure 3.10 C, at fundamental frequencies ranging from ~ 10 to 20 kHz, 2nd harmonic 
overshoot (taking values larger than the pre-furosemide values) was observed in the period of 47 
– 89 min, while by 108 min, the 2nd harmonic had decreased. From the analysis of Figure 3.9 B, 
this indicates that the OP of the MET transduction curve was first moving away from the center of 
the IO function, and then re-centering. At the same time, the fundamental and 3rd harmonic first 
decreased and then substantially recovered, which is also as expected with a de-centering and then 
re-centering of the OP (Figure 3.10 E) (74). 
 
Figure 3.10  Fundamental (A, B), 2nd harmonics (C, D), and 3rd harmonics (E, F) of LCM frequency responses 
before and after IV 100 mg/kg furosemide injection. Their amplitudes and phases are plotted against the 
fundamental frequency, with BF, BF/2, and BF/3 labelled. (expt696)  
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In expt705, with the purpose of exploring the time-variation of the LCM nonlinearity in 
more detail, LCM was measured from 30 – 90 dB SPL in 5 dB steps. To attain a fine time resolution, 
only single-tone LCM was measured and responses were measured at only two stimulus 
frequencies: the 18 kHz BF, to show the cochlear amplification variation; and 9 kHz as a sub-BF 
frequency, in order to measure MET channel nonlinearity relatively independent of cochlear 
amplification. With this protocol a full set of LCM data could be collected as often as once every 
2 minutes. LCM measurement time points are indicated in the gray boxes included with the EP 
data of Figure 3.11 E. Figure 3.11 A – D show the LCM variation at 18 kHz, and Figure 3.11 F – 
H show the variation at 9 kHz. Because the decreasing driving voltage leads to a decrease in the 
amplitude of both fundamental and harmonics of the LCM, the 2nd harmonic amplitudes are 
shown normalized to the fundamental (Figure 3.11 C&G).  
 
Figure 3.11 LCM variation after IV furosemide injection in response to 30 – 90 dB SPL tones (expt705) with 
fine time resolution (measurement time points shown in E as gray squares). EP variation shown in E. LCM 
response is shown at two frequencies, BF = 18 kHz (A – D), and subBF = 9 kHz (F – H). See Figure 3.2 D for 
this preparation's full frequency response before furosemide injection. At 58 – 80 min (gray shaded areas), 
the cochlear amplification and 2nd harmonic of LCM recovered, without a corresponding EP change. 
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After furosemide injection, 2nd harmonic overshoot was observed starting at 12 min at 
both 9 and 18 kHz. From our harmonic simulation (Figure 3.9 B), this indicates that the OP of the 
MET transduction curve was moving away from the center of the IO function. The LCM 
fundamental frequency amplitudes at both frequencies showed an immediate decrease followed 
by a recovery (similar to Figure 3.8), and the fundamental amplitudes were stabilized at ~ 10 min. 
From 10 – 58 min, the LCM amplitude at the BF (18 kHz) remained unchanged, and at the sub-
BF frequency (9 kHz) mildly increased. At 58 – 60 min (gray shaded area in Figure 3.11), the 
cochlear nonlinearity at the BF (Figure 3.11 B), which up to this point was only apparent at high 
SPL (passive nonlinearity), emerged at 30 – 60 dB SPL, thus active nonlinearity recovered 
significantly in this period. In contrast, there was no noticeable EP change in this period (similar 
to Figure 3.8). Instead, the 2nd harmonic amplitude response at both stimulus frequencies (Figure 
3.11 C&G) decreased, indicating that the OP was re-centering at the time (recall Figure 3.9 B). 
Thus, the recovery of cochlear amplification during the gray-shaded time period was not due to a 
recovery in driving voltage, but instead likely resulted from a shift in the MET OP. We expect that 
the driving voltage was already sufficiently recovered to generate cochlear amplification as early 
as the 30 min time point, but because at that time the MET OP was substantially off center, the 
transduction current was too small to generate active nonlinearity. As a final note, the phases of 
the 2nd harmonics at the time were approximately flat and zero or 1/2 cycle (Figure 3.11 D&H), 
supporting that the measured harmonics were generated from local LCM distortion.  
Figure 3.12 shows how the fundamental and normalized 2nd harmonic changed in time in 
two additional preparations, in which the full frequency range was probed. Both of the animals 
showed 2nd harmonic overshoot through frequencies below their BF. This overshoot was 
maximum at frequencies near the BF (bright spot in Figure 3.10 B&D). That the BF region shows 
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the maximum overshoot of 2nd harmonic/fundamental is in part due to the greater loss of the BF 
fundamental, which exaggerates the increase of 2nd harmonic when normalized by the 
fundamental. However, normalization is not the sole reason for the overshoot; recall that Figure 
3.10 C showed that the 2nd harmonic overshoot occurs in absolute terms, not only in relative terms.  
 
Figure 3.12 Fundamental and 2nd harmonic change in full frequency range for two animals (A – B: expt696, 
C – D: expt718) after 100 mg/kg furosemide IV injection at 0 min, plotted versus fundamental frequency and 
time of measurement. A&C show fundamental amplitudes in dB SPL; B&D show 2nd harmonic amplitudes 
relative to fundamental amplitudes (unit less). The closed triangles indicate the BF.  
3.4 Discussion 
Based on their findings of recovery of DPOAE with low EP (following IP furosemide), 
Mills et al. hypothesized that cochlear amplification could recover with reduced EP (69). This 
hypothesis is related to the fundamental question of how the cochlea maintains operating 
conditions so that transduction and cochlear amplification can function properly. The cochlear 
amplification of the basal region of the cochlea is remarkable, with peak-region motion gain factors 
of many hundreds in the healthiest preparations (37, 42, 122). The high frequency region of the 
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cochlea is also remarkably fragile, which makes probing this region in experimental animals 
challenging for scientists, and impacts the high frequency hearing of aging humans. This fragility 
suggests that minor perturbations in operating conditions can have serious detrimental effects. The 
primary objective of this study was to better understand the recovery, and therefore maintenance, 
of cochlear operating conditions. We explored this primarily through the LCM, measured close to 
the BM, and simultaneous measurements of EP. The LCM represents the transducer current 
through local OHCs (41, 82) and shows the tuned response and compressive nonlinearity in the 
peak of the response curve that is the hallmark of cochlear amplification (Figure 3.2). In the LCM, 
nonlinearity extended through the low frequency region at SPLs greater than ~ 75 dB SPL, and 
this saturating nonlinearity is expected due to the saturation of transducer current when the 
channels are approaching their fully open and closed states. 
The maintenance and recovery of cochlear operating condition has been studied by others, 
and a commonly analyzed aspect of operating condition is the operating point (OP) of the 
mechano-electric transduction channel. The channel operates over a range of less than 0.2 μm 
(123), which is easy to imagine being perturbed by small static changes in the 10 – 100 μm sized 
cells and tissues of the cochlea. Small shifts in OP are likely to lead to substantial changes in 
cochlear amplification, because OHC electro-motility and electro-forcing are driven by OHC 
current-induced voltage (49, 50, 85, 91, 124). To give examples of this previous work, Kirk et al. 
(99) followed low frequency CM and f2-f1 DPOAEs during and after delivery of a high SPL low 
frequency tone, and hypothesized a quasi-static mechanical shift gave rise to the known bounce of 
sensitivity. They modeled their results with a Boltzmann function representing the transducer 
input-output (I-O) curve. Salt and colleagues (75) measured low frequency CM and DPOAEs to 
follow OP changes following several perturbations, including endolymphatic injections and 
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furosemide administration. One of the objectives of their studies was to explore the use of cochlear 
distortion as an indicator for endolymphatic hydrops. Changes in cochlear responses with low-
frequency bias tones have been studied, with the responses following predictable patterns of 
saturation (125-128). Our analysis below also traces OP changes following perturbation, and goes 
beyond previous studies by monitoring changes in LCM at multiple SPLs and many frequencies, 
including the local best frequency, simultaneously with EP. These measurements allowed us to 
directly monitor cochlear amplification and its variation with low EP. Our measurements of DPs 
and DPOAEs added to the study but the LCM was the central measurement used for analysis.  
3.4.1 Cochlear amplification recovered simultaneously with operating point re-
centering 
We found the LCM harmonics changed after furosemide injection, indicating the MET 
channel OP shifted during the measurement. The delayed recovery of the OP compared to EP 
recovery likely resulted in the delayed recovery of cochlear amplification. Here we quantify this 
notion, using the 2nd harmonic variation and the OHC MET Boltzmann model introduced in 
Section 3.2.1 (and Figure 3.9) to calculate the time-variation of the OP.  
The parameters of the Boltzmann model were determined by fitting the expt705 data 
(experiment from Figure 3.11 A), and the method was described in Section 3.2.2. The response at 
8 min after furosemide injection was chosen to generate the Boltzmann model as explained here: 
(i) At 8 min, the cochlear amplification was nearly inactive. Our objective was to generate and 
then use the MET curve, where, strictly speaking, input is stereocilia deflection and output is 
transducer current. Our measured input is SPL. However, when the cochlear amplifier is inactive, 
sound pressure and stereocilia deflection likely scale approximately linearly. (ii) 8 min after 
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furosemide injection, the amplitude of the normalized 2nd harmonic reached its minimum, which 
means the transduction curve was the most symmetric at that time. Therefore, the constructed IO 
curve was not much affected by the fact that our metal-electrode measurement of LCM was AC-
coupled. (Truly, even with a DC-coupled electrode, measuring OHC-based DC responses would 
not have been possible, since the DC response could have a substantial contribution from IHCs 
(83).)  
 
Figure 3.13 (expt705) See Figure 3.2 D and Figure 3.11 for more information. Furosemide injected IV at 0 
min. Color map shown in B. A) EP variation. B) Normalized LCM at BF = 18 kHz. C) OP change. Estimated 
from the 2nd harmonic response of BF at 65 dB SPL (blue), 85 dB SPL (red), and sub-BF 9 kHz 65 dB SPL 
(green), by Boltzmann model shown in Figure 3.9 B&C. During the cochlear amplification recovery from 58 
– 80 min (gray shade) no significant EP change was observed, but the OP showed a significant recovery/re -
centering.  
Once the Boltzmann curve was known (Figure 3.9 A for example), we determined where 
the OP was on the curve at subsequent time points using the LCM 2nd harmonic response, 
normalized by the fundamental response at these time points, by the scheme of Figure 3.9 B&C. 
OP time-variations were found for three separate frequency/SPL combinations, to check 
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consistency. These three were the responses at 9 kHz, 65 dB and 18 kHz, 65 dB and 85 dB SPL 
stimuli (recall the BF = 18 kHz). In Figure 3.13, the time course of the OP is in C, compared with 
the EP (A) and normalized fundamental LCM, representing cochlear amplification, in B. Figure 
3.11 D&H show that the 2nd harmonic phase re the fundamental was either 0.5 or 1 cycle from 0 
to 90 minutes, as predicted for a locally-generated nonlinearity, which our analysis assumes 
(Figure 3.9 C). However, before the furosemide administration and after ~100 min the phase values 
could diverge from these two values, indicating that at these times some of the 2nd harmonic 
response likely was generated non-locally and travelled to the measurement location (122). 
Figure 3.13 C shows that the three OP estimates resulted in similar OPs, which supports 
the validity of the OP estimate. (The 18 kHz 65 dB SPL OP estimation could not be found beyond 
~ 40 mins, likely because the return of amplification prevented the linear proportionality between 
stereocilia deflection and sound pressure.) An OP change in the negative direction corresponds to 
MET channel closure (Figure 3.9 F&G), so that the OHC is operating in a more hyperpolarized 
state. This is expected to occur for a static position shift of the BM towards ST. Similarly, a positive 
OP change corresponds to a relatively depolarized OHC, which is expected for a static position 
shift of the BM towards scala vestibuli (SV) (Figure 3.9 H&I). To describe the time-course of the 
OP variation, and speculate on its basis: The OP started at +0.06 Pa after the furosemide injection. 
At 11 min, the OP passed 0 and jumped to -0.071 Pa, then shifted slightly more negative slowly, 
reaching its minimum at ~50 min. The minimum OP change was ~ -0.15 Pa, which is ~ 20% of 
the extent of the Boltzmann curve in Figure 3.9 A. In Peng et al. (123) Figure 2, 20% of the input-
output function is ~ 10 nm of stereocilia tip displacement, and we can approximate the OP point 
shift as corresponding to a BM position shift of this magnitude. In this scenario, the OP change 
was induced by the decreased driving voltage hyperpolarizing the OHC soma, causing the OHC 
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to lengthen and shift the position of the stereocilia. However, the mechanism for OP shift is not 
revealed by this study.  
At 58 – 80 min (shaded area in Figure 3.13), the OP was significantly re-centered. This 
recovery was simultaneous with cochlear amplification recovery, evinced by the recovery of 
nonlinearity in the LCM at low SPL (Figure 3.13 B). This simultaneous recovery indicates that 
recovery of cochlear amplification was due to OP re-centering and was not directly tied to EP 
recovery (Figure 3.13 A). With the OP substantially re-centered, the MET transduction operates 
in a more linear region with larger MET currents and thus greater OHC electromotile forcing. 
Additional changes that facilitate amplification could occur along with OP re-centering.  
There are several time points where the OP affected the LCM. At 10 min, the phase of the 
2nd harmonic shifted by a half cycle (Figure 3.11), indicating that the OP jumped from positive to 
negative (Figure 3.13 C). At this time point, the amplitude of BF and sub-BF fundamental 
responses showed a moderate peak, and the 2nd harmonic amplitude showed a valley (Figure 3.11). 
These changes were also observed in other preparations (Figure 3.8 D&E, Figure 3.12 at ~ 10 min, 
Figure 3.4 at ~ 50 min instead of 10 min because of IP injection). In our earlier paper (129), we 
compared the experimental LCM with the expected "Ohmic" LCM change due to the change in 
driving voltage, using the Davis model (67). The higher SPL data (85 dB) was better predicted by 
the simple Ohmic prediction than the lower SPL data (30, 45 and 65 dB), likely due to the smaller 
contribution of cochlear amplification at 85 dB SPL. Nevertheless, the Ohmic prediction and 
experimental LCM still differed at 85 dB SPL. This previous finding is consistent with the finding 
from the present analysis, that in addition to reducing the driving voltage, the furosemide injection 




Sirjani et al. (75) administered IV furosemide at 100 or 50 mg/kg in guinea pig, monitored 
2nd harmonics in CM in response to 500 Hz tones measured near the RW, and estimated OP shifts. 
Responses were followed for 32 minutes. Despite the experimental differences (frequency and 
location of CM measurement), the observed variations (Figure 9 in (75)) mostly agree with our 
results in Figure 3.11 and Figure 3.13. In their results, the 2nd harmonic showed an initial rapid 
increase, then decreased to a local minimum at 10 min (still larger than the original), and then 
stabilized or increased slightly. The calculated OP shifted towards SV immediately after the 
injection, and slowly moved towards ST, passing 0 at ~ 15 min. Sirjani et al. did not observe full 
recovery of the OP, but they only observed for 32 minutes, where in our result the OP was ~ fully 
recovered at ~ 240 min. Their measurement of DPOAE 2f1-f2 emissions showed a decline 
followed by an increase, which was also similar to our observation (Figure 3.7).  
3.4.2 Variation of odd harmonics support the proposed OP change 
Theoretically, with OP change, odd order distortions such as 3rd harmonics and 2f1-f2 DP 
will show a “W” shape, with a local maximum with the OP at zero, a decrease with OP shift in 
either direction away from zero, and finally an increase at larger OP shifts (74). Using our 
Boltzmann simulation with 65 dB SPL stimulation, 3rd harmonics are expected to decrease as OP 
moves away from zero for OP shifts that are < 0.2 Pa. During experiments the 3rd harmonic was 
often nearly beneath the noise level due to its small amplitude. Nevertheless, it showed a 
significant decrease after furosemide injection and a recovery afterward (Figure 3.10 E). Figure 
3.14 shows the DP variation with IV injection through a frequency range of f2 = 5 – 30 kHz, for 
two preparations. The amplitude variations are shown in dB Volts (A, B and E, F) and in dB change 
relative to their initial values (C, D and G, H). Both preparations showed a decrease in DP after 
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furosemide injection, followed by recovery. These variations of odd order distortion support the 
OP variation predicted with the 2nd harmonic analysis. 
 
Figure 3.14 DP (2f1-f2) after 100 mg/kg furosemide IV injection at 0 min. (Same preparations as in Figure 
3.7. A – D: expt696, E – H: expt718) Amplitudes are in dB Volts (A, B, E, F). dB changes in C, D, G, H were 
referenced to their initial values before furosemide injection. The closed triangles ind icate the DP frequency 
that corresponding to f2 = LCM measurement BF, and the open triangles indicate f1 = LCM measurement BF.  
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3.4.3 Basis for the OP shift under EP change  
The OP shift at 10 – 50 min in our Figure 3.13 might be due to the mechanical effects of 
reduced EP.  Reduced EP would decrease OHC transmembrane potential and thus hyperpolarize 
the OHC, which would increase its static length due to electromotility. As noted above, the OP 
shift corresponded to ~ 10nm of stereocilia displacement. OHC static length change is ~ 2 – 15 
nm/mV in isolated OHCs (85), but in the more constrained in-vivo state, OHC static length change 
is expected to be reduced. However, in an in-vitro preparation of the whole cochlea Jacob et al. 
(68) found that positive current injection into SM caused position shifts of up to 200 nm, thus the 
~ 10 nm shift we estimate is reasonable. EP changes induced by hypoxia have been correlated with 
OP shifts in past work (74): Using a Boltzmann-based analysis, 40 mV of brief (~ 5 min) EP 
decrease caused < 0.1 Pa shift corresponding to displacement towards SV, followed by a 0.3 Pa 
shift corresponding to displacement toward ST. The OP reached its maximum (toward ST) at the 
same time EP reached its minimum. The displacement toward ST is as expected if the main effect 
of reduced EP was to hyperpolarize the OHC. The mechanism and time-course of EP reduction in 
the above study (18) are different than in our study, and the specifics of the OP responses are 
different, but in both studies the responses can be thought of in terms of static position shifts 
brought on by OHC electromotility.  
Furosemide may result in an OP change through mechanisms other than reduced EP. 
Santos-Sacchi et al. (130) showed that furosemide can affect nonlinear capacitance in isolated 
OHC. Sirjani et al. (75) found that the OP variation caused by RW perfusion with furosemide was 
different than that caused with IV injection, indicating that furosemide might affect different 
pathways in the cochlea. However, in Rybak 1979’s results (131), perilymph concentrations of 
furosemide with IV injection reached only low micromolar concentrations (~15 uM), which was > 
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6 times smaller than the amount that was able to alter nonlinear capacitance in the isolated OHC 
(> 0.1 mM). Furthermore, the perilymph concentrations of furosemide required to alter cochlear 
function with perilymphatic injection (10-4 – 10-3 M, (132)) are 1000 times greater than with the 
EP-reducing IV injection (1.5×10-6 M, (131)) (51). These observations indicate the primary 
cochlear site of action of furosemide is at the stria vascularis and not the hair cells or other cells of 
the organ of Corti. OHC degeneration has been observed as a result of primary strial dysfunction 
(133), but only in relatively long-term studies (71, 133, 134).  
Furosemide blocks Na, K-ATPase or NKCC in the marginal cells of stria vascularis (and 
other cells) (13, 75), and alters the ionic composition of cochlear fluids as well (specifically K+ 
and Cl- (75, 112, 119)). In Rybak and Morizono (119), the IV injection of furosemide reversibly 
decreased the endolymph K+ concentration (termed Ke+), and its recovery (starting at ~ 25 min) 
tended to lag behind the EP recovery. This time course of Ke+ could affect LCM since potassium 
acts as the primary cation for OHC transduction current. Rybak and Whitworth (112) showed 
endolymph Cl- concentration decreased by 16 mM in 30 min when they IV injected 100 mg/kg 
furosemide, and [Cl-] recovery lagged the EP recovery. Chloride is essential to the electromotility 
of the OHC motor protein prestin (86, 87). Decrease of extracellular and intracellular Cl- had been 
shown to decrease the peak capacitance and the operating voltage of prestin (21, 87, 135, 136), 
which leads to a reduction in cochlear amplification. On the other hand, the reduction of those ions 
may be accompanied by osmotic changes in endolymph, which could affect OP (75, 103). Finally, 
the OHC MET channel is sensitive to intracellular [Ca2+] and the reduced voltage drive for this 
divalent cation might have led to reduced Ca2+ flow into OHCs, affecting stereocilia position and 
OP (76, 137). In summary, our experimental results show that recovery occurs simultaneously 
with re-centering of the OP of OHC MET channels. However, recovery might also hinge on the 
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recovery of proper ionic concentrations and OHC resting potential, required for prestin to return 
to a functional state (94, 135, 138).  
EP reduction has been shown to be a primary factor of metabolic presbycusis (71). In aged 
gerbils with low EP, CM measured at the RW was comparable to or even larger than in young 
gerbils (139). These data were explained by a “dead battery” model, in which the strial battery 
source resistance was increased in aged animals (140). However, in acute application (such as 
furosemide application or current injection to SM), CM has been positively correlated with EP (72, 
141) and our experimental data are in keeping with this. The present study was of acute changes 
in EP and the observations here are not expected to be similar to those due to the long-term 
reduction of EP that occurs in aging. Certainly, it would be interesting and beneficial if OP 
adjustment could reduce the deleterious effects of metabolic presbycusis, but this study does not 
address that question.   
3.4.4 BM motion and neural response with reduced EP  
In experiments with IV furosemide administration in chinchilla the BM velocity at BF 
recovered over a similar time scale as our LCM: the BM velocity nonlinearity was not recovered 
at 45 min and was recovered 118 min (51). However, EP was not measured in those experiments.  
In experiments with IV-furosemide administration in cat, auditory nerve response and EP 
were measured and recovered simultaneously, which is different than the delayed recovery of 
LCM in our results (70). This difference might be related to the much smaller dose of furosemide 
(7.5 mg/kg) in the experiment in cat, which only decreased EP to 10 mV, with nearly full recovery 
within 10 min.  
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CAP threshold is an indicator of cochlear sensitivity based on auditory nerve signals. It is 
an indicator of low-SPL responses and thus depends strongly on cochlear amplification. In 
experiments in cat, the relationship between EP change and CAP threshold was found to have a 
slope close to -1.0 dB/mV (70, 71, 142). In our experiments, comparing initial CAP threshold to 
that at the end of the experiment, our results are consistent with this value (Figure 3.1), in that a 
final EP decrease of ~ 10 mV caused CAP threshold elevated ~10 dB in two animals. In one animal, 
the final EP was decreased 20 mV and CAP threshold was elevated 20 – 30 dB. We did not monitor 
CAP at intermediate time points. When EP was reduced by methods other than furosemide, for 
example mutant mice or noise exposure, the relationship between CAP threshold and EP was 
closer to -0.5 dB/mV (142). However, with these methods, factors other than EP likely contribute 
to the threshold elevation.  
3.5 Conclusion 
With IP furosemide injection, we reproduced the result by Mills et al. (69), in which, 
following an initial reduction, the DPOAE recovered before the EP. Since DPOAE is a 
noninvasive measure of cochlear status, Mills et al. hypothesized that the earlier DPOAE recovery 
indicated that cochlear amplification recovered before EP. With IP furosemide, our findings with 
direct measurement of cochlear amplification did not support this hypothesis: cochlear 
amplification, as measured via LCM, began its recovery with a similar time course as EP. 
Compressive nonlinearity in the peak region recovered in stages, at the highest SPL first and the 
lowest SPL last, and with IP furosemide the recovery of peak-region compression was incomplete 
in the presence of stabilized, but not fully-recovered EP. Our interpretation of the full recovery of 
DPOAE and incomplete recovery of cochlear amplification as measured in LCM is that DPOAE 
is a relatively simple indicator of cochlear sensitivity. DPOAEs represent distortion, which relies 
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on cochlear nonlinearity, but DPOAEs are not necessarily monotonically related to cochlear 
amplification. As another example, an earlier experiment showed 2f1-f2 DPOAE did not change 
significantly when CM amplitude was reduced by 10% and CAP threshold was elevated by ~ 6 dB 
(101).  
With IV injection of furosemide, several aspects of the results were similar to those with 
IP injection, namely, reduction in DPOAE, LCM and EP, followed by recovery. However, many 
aspects of the results were different. Most significantly, the cochlear amplification observed in 
LCM could attain nearly full or even full recovery with ~ 20 mV reduced EP (as shown in Figure 
3.8). Thus, as Mills et al. hypothesized, the cochlea has an ability to adjust to diminished operating 
condition. Furthermore, the cochlear amplifier and EP recovered with different time courses: 
cochlear amplification just started to recover after the EP was nearly fully recovered and stabilized. 
Using a Boltzmann model and the 2nd harmonic of the LCM to estimate the transducer OP, we 
showed that this non-simultaneous recovery of cochlear amplification happened along with a shift 
in the OP. These observations suggest that cochlear amplification is capable of adjusting to lower 






Chapter 4 Cochlear perfusion with a viscous 
fluid 
4.1 Introduction 
Cochlear perfusion is a useful technique to alter the fluid within the cochlea. A viscous 
fluid induces high shear forces when the fluid is flowing. This physical property enables cochlear 
perfusion with viscous fluid to produce pressure/force in cochlea. Salt et al. (103) injected highly 
viscous fluid into the apex of the cochlea to mechanically displace the OC in vivo and investigated 
sensitivity changes. On the other hand, the flowing fluid may damage the cochlear structures. Our 
prior study presented a novel perfusion-based method for cochlear implant (CI) electrode insertion 
(106), using perfusion of a viscous fluid (0.5% HA, Healon, Abbot Labs Inc.) to guide the CI 
insertion. The shear forces produced by the flow of viscous fluid successfully brought the CI 
electrode deeply into cochlea (or a desired insertion depth), and the flow of the lubricating fluid 
prevented the CI from penetrating delicate cochlear structures. However, CAP thresholds were 
elevated, perhaps because of the large shear stress on intracochlear fluid/tissue boundaries. To 
further develop the injection-insertion technique, a fluid with suitable viscosity needs to be found, 
to minimize the damage while still being able to carry the CI within the cochlea. From a research 
standpoint, this study provides experimental data for the viscosity effect on cochlear mechanics. 




HA is a viscoelastic and biocompatible fluid widely used in eye surgery (143) and also 
used as a lubricant that is placed in the RW during cochlear implantation. In this work the 
physiological and anatomical effects of perilymphatic perfusion of HA of various concentrations 
and viscosities were examined in vivo in gerbil. 
This chapter is largely derived from the publication (102). 
4.2 Materials and Methods 
4.2.1 Cochlear perfusion system set up 
Cochlear perfusion in the cochlear perilymphatic space is a useful technique to alter the 
fluid within the cochlea. For whole perilymphatic perfusion, we needed to seal the gap between 
the perfusion tubing and the SV opening in order to create a leak-free system and maintain an 
accurate perfusion rate. This made it challenging to change the perfusion fluid while experimenting, 
since reattaching the inlet tubing can easily damage, or introduce bubbles into the cochlea. To 
overcome this difficulty, a reverse perfusion method was used (Figure 4.1 and Figure 4.2). Instead 
of infusing the fluid, the perfusion pump was set to a withdrawal mode. While perfusing, the 
perfusion fluid entered ST through the open RW, flowed up to the apex and back down and out 
through the SV hole, thus perfusing the cochlear perilymphatic space. 
To implement the reverse perfusion, the following system was used: The RW opening was 
filled slowly by hand with perfusion fluid using a syringe with a soft rubber needle. Fluid in the 
RW opening was gently wicked out with soft tissue paper each time before changing the perfusion 
fluid. The SV hole was plugged with a prepared cochlear perfusion cannula as illustrated in Figure 
4.1 B, and its tip was glued to the SV hole with dental cement (DurelonTM Carboxylate Cement). 
The perfusion cannula consisted of a 4 mm piece of polyamide-coated glass tubing (Polymicro 
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Corp.) (151 μm o.d., 75 μm i.d.) with one end connected to a 5 cm length of capillary (1.5 mm 
o.d., 0.75 mm i.d.), which was itself connected to a perfusion pump (WPI’s UltraMicroPump III 
with microprocessor controller Micro4TM). The tip of the Polymicro tubing was cut flat to avoid 
trauma to intracochlear structures. To produce a precise and constant perfusion rate, firm tubing 
was chosen and the perfusion pump was set at a microstep mode. All the parts of this cannula were 
connected using silicone rubber to ensure it was air and water tight. 
 
Figure 4.1 Diagram of cochlear perfusion. A: Set up of the perfusion system. The gray color indicates the 
fluid space, and the arrow indicates the flow direction. Perfusion fluid was supplied to the ST space at the 
open RW with a soft syringe, and pulled out from the basal SV hole by a perfusion pump in withdraw mode. 
The SV hole and perfusion pump were connected by a perfusion cannula (illustrated in detail at B), with one 
side inserted into the SV hole and the other side connected to the perfusion pump. The gap between the tip of 
the perfusion cannula and the SV hole was sealed by dental cement to create a leak-free perfusion system. B: 
Detailed diagram of perfusion cannula. The tip that was inserted into SV (left side in the figure) was composed 
of a polyimide-coated glass tubing and a capillary. A length of tubing connected the  tip to the syringe pump. 
The different parts of the perfusion cannula were glued together with silicone rubber. This figure is similar to 
that in our published paper (102).   
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The perfusion pump was set to withdraw the fluid through the perfusion cannula at a 
controlled perfusion rate. For our general study, a 10 min perfusion with 2.4 μL/min rate was 
applied to perfuse the whole ~ 3 μL perilymphatic space several times over (144). This made up 
for any residual fluid in the RW opening.  
 
Figure 4.2 The cochleostomy can be seen in the SV, and the RWM was torn so the perfusion fluid could enter 
the cochlea. A: Experimental photo with cochlea structure labeled. Apex of the cochlea wa s covered by 
eardrum, thus is not visible here. B: Corresponding sketch, with eardrum removed. The wall of the SM is 
represented in blue. Drawing by Vanessa Cervantes.  
4.2.2 Perfusion fluid preparation 
In this experiment, both artificial perilymph (AP) and Healon (HA, Abbot Labs Inc.) were 
used for perfusion. AP served as a control to ensure that perfusing this low-viscosity fluid did not 
damage the cochlea. HA was the experimental fluid in different concentrations / viscosities. 
Generally, HA with higher concentration has higher viscosity (145). Four different concentrations 
were prepared (0.0625%, 0.125%, 0.25% and 0.5%) by diluting 1% HA with AP (NaCl 125 mM, 
KCl 3 mM, NaHCO3 25 mM, CaCl2 1.3 mM, MgCl2 1.2mM and NaH2PO4 0.75mM, in a pH of 
7.4) (146). The fluids were at room temperature (25 °C) before use. 
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4.2.3 Shear stress estimation 
The maximal shear stress produced by perfusing viscous fluid through the whole 
perilymphatic space of the cochlea can be estimated. Assume the perfusate as a Newtonian fluid, 
therefore the shear rate and shear stress can be found in a straightforward manner. Regarding the 
uncoiled gerbil cochlea as a circular tube and taking the perfusion flow as laminar, the shear stress 
at the wall of the cochlea is: 
 𝜏 = 𝜇𝛾?̇? (4.1) 








Q is the volume flow rate, corresponding to the perfusion rate of 2.4 μL/min. R is the radius, 
~ 118.5 μm for this calculation. According to the anatomical data (http://oto2.wustl.edu/ 
cochlea/mrgbvol.htm), over a large fraction of their length ~ 3 – 7 mm from base (~ 8 mm was the 
total), both SV and ST have nearly constant cross sectional areas. In the noted range, the area of 
SV is slightly smaller than ST, and we used SV for our calculation of shear stress. We regarded 
the cross sectional of SV as a circle, calculated the radius and used the average over the 
aforementioned length range for R in Eq. (4.2). According to the above estimations the shear rate 
on the scala wall was 30.6 s-1; it will be smaller in the basal region where the areas are larger.  


















To calculate pressure, the varying cross sectional areas of SV and ST were used. x is the 
distance from the base of gerbil cochlea. rSV(x) and rST(x) are the radius of SV and ST as a function 
of distance. LSV and LST are the total lengths of the uncoiled SV and ST. 
4.2.4 Histology method 
Histology was used to examine the impairment of cochlea in cellular level. The process of 
sample preparation includes fixation, dehydration, infiltration, embedding, sectioning, and staining. 
After euthanasia, the experimental cochlea was gently perfused with fixative (2.5% glutaraldehyde, 
1.5% formaldehyde in 0.065M sodium phosphate buffer at pH of 7.3) using the perfusion system 
that was established. The cochlea from the other side was used as a control, and in that cochlea the 
RW and oval window were opened to circulate the fixative. Both the experimental and control 
cochleae were removed from the temporal bones and immersed in fixative for 24 hours. They were 
then decalcified in a 120 mM EDTA (at pH of 7) solution for 6 days, and washed in phosphate 
buffer. After decalcification, the cochleae were dehydrated with increasing concentrations of 
ethanol, and then with increasing concentrations of polypropylene oxide (PPO) initially diluted by 
ethanol. The cochleae were then permeated with increasing concentrations of Embed 812 Mixture 
(21 mL Embed 812, 13 mL DDSA, 11.0 mL NMA, 0.7 mL DMP30) in PPO. Finally, the 
specimens were embedded in Embed 812 Mixture kept at vacuum for 24 hours and then cured in 
a 60°C oven for 24 hours. Sections were cut at a thickness of 1.5 μm and mounted on glass slides, 




4.3.1 CAP thresholds were elevated after perfusion with viscous fluid 
Our goal was to investigate the highest value of viscosity that the cochlea could be perfused 
with, while maintaining ~ normal CAP thresholds. The experiment started with AP perfusion, 
followed by HA concentrations from low to high. For each concentration, as noted in Section 4.2.2, 
a 10 min perfusion with a rate of 2.4 μL/min was applied. 
 
Figure 4.3 CAP threshold change after cochlear perfusion with different fluids. Data from gerbil expt483 are 
shown in A and C and the data from gerbil expt523 are shown in B and D. AP, 0.0625% HA, 0.125% HA, 
0.25% HA, and 0.5% HA were perfused sequentially at the rate of 2.4 μL/min, in the order of increasing 
viscosity. Baseline thresholds were measured just after the bulla was opened. Pre -perfusion thresholds were 
measured after the cochleostomy was made and the perfusion cannula was cemented to the cochlea. A, B: 
CAP threshold curves after cochlear perfusion; C, D: Corresponding CAP threshold shift compared with pre -
perfusion. 0.5-20 kHz stimulus range is shown. For 0.125% and 0.25% HA perfusion, several CAP thresho ld 
measurements were made after perfusion and the stabilized thresholds are shown.  
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Figure 4.3 shows the CAP threshold change of two ears: A and C for the first, B and D for 
the second. For 0.125% and 0.25% HA perfusions, the thresholds that were obtained after they 
stabilized are shown; these were measured ~ 40 min and 60 min after the perfusions respectively. 
Figure 4.3 A shows that the pre-perfusion CAP thresholds taken after fixing the perfusion 
apparatus and removing the RWM were similar to baseline (< 5dB change). Similar results were 
also found in our other experiments. Those findings indicate that opening the RW, making the 
cochleostomy, and gluing the perfusion cannula induced little trauma. Figure 4.3 C and D show 
that the AP perfusion had little effect on thresholds, and with increasing concentrations of HA, the 
thresholds increased. The threshold elevation after 0.0625% HA perfusion was small, but after 0.5% 
HA perfusion the thresholds were > 90 dB SPL. The 0.125% concentration was a borderline case 
in that it was damaging in one case (Figure 4.3 A and C) and relatively mildly damaging in the 
other (Figure 4.3 B and D).  
Following perfusions in which CAP thresholds were elevated, thresholds were measured 
several times over ~ 1 hour to see if thresholds would recover. Since after 0.0625% HA perfusion 
the threshold elevation was small, and after 0.5% HA perfusion the CAP thresholds were greatly 
elevated and altered in character, only 0.125% and 0.25% HA perfusion were used to study the 
CAP threshold recovery. Figure 4.4 compares shifts in CAP thresholds measured immediately 
following HA perfusion to those measured some time later. The data are from the same two 
cochleae as in Figure 4.3. Both after 0.125% and 0.25% HA perfusions, the thresholds recovered 
to some degree and stabilized at a new level. Thresholds after 0.125% HA perfusion improved by 
as much as 20 dB within 20 min, to a level where they stabilized, while for 0.25% HA perfusion 




Figure 4.4 CAP threshold stabilization after cochlear perfusion with viscous fluid. Data are from the same 
animals as in Figure 4.3, A, C for expt483, and B, D for expt523. A, B: CAP thresholds after 0.125% HA 
perfusion, measured at the time just after perfusion (0 min), and ~ 20 and ~ 40 min later. C, D: CAP thresholds 
after 0.25% HA perfusion, measured at the time just after perfusion (0 min), and ~ 20, ~ 40 and ~ 60 min later. 
 
Figure 4.5 CAP threshold change after cochlear perfusion with 0.0625%, 0.125% and 0.25% HA. CAP 
threshold curves from three animals perfused separately with A:  0.0625% HA, B: 0.125% HA and C: 0.25% 
HA are shown. Each cochlea was perfused first with AP, followed by HA. Thresholds after 0.125% and 0.25% 




To further examine the effect of HA perfusion, cochlear perfusion with 0.0625% HA, 0.125% 
HA and 0.25% HA were investigated individually in different cochlea. Each perfusion started with 
a 10 min 2.4 μL/min AP perfusion as a control. Figure 4.5 shows the CAP threshold changes from 
three cochleae perfused with HA of each of these concentrations. Similar to the results of Figure 
4.3, 0.0625% HA perfusion (Figure 4.5 A) resulted in almost no elevation of CAP thresholds, but 
0.125% and 0.25% HA perfusion (Figure 4.5 B and C) resulted in significant elevation. Following 
the 0.125% and 0.25% HA perfusions, CAP thresholds were also measured several times and 
threshold recovery was observed to be similar to Figure 4.4. 
The results presented above showed that perfusion of certain HA concentrations 
consistently did (0.5%) or did not (0.0625%) cause trauma, while in the mid-range of 0.125% and 
0.25% HA, cochleae responded to the perfusions with various threshold elevations and recoveries. 
Likely the range of responses is related to the cochlear morphology; perhaps the less traumatized 
cochleae had wider cochlear scalae compared to the other cochleae (147), so that smaller shear 
stresses were produced. 
4.3.2 CAP waveform changed after perfusion 
In addition to the elevation of CAP thresholds, the CAP response waveforms changed after 
perfusion with the relatively concentrated HA solutions. Figure 4.6 shows an example. The 
stimulus was a 4 kHz tone pip. Along with the threshold recovery illustrated in Figure 4.4 and 
Figure 4.5, the CAP response waveform also recovered over time. After 0.5% HA perfusion, in 
addition to the pronounced CAP threshold elevation, the CAP waveform showed an altered peak 
structure and latency. In the baseline condition, the CAP response normally started with a valley 
N1 followed by a peak P1, followed by several small additional waves. The largest peak is P1, 
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with latency in the range of 3.7-4.2 ms, gradually decreasing with the increasing stimulus level. In 
contrast, after the 0.5% HA perfusion, the response started with a peak P0 at 2 ms, following by 
several large valleys and peaks. The P0 was not always the largest peak and was only evident at 
high stimulus level. This short latency P0 also appeared after some low concentration perfusions 
(as labeled in Figure 4.6), but those CAP responses still started with a deep valley. A P0 was also 
found in some healthy CAP responses (Figure 4.7 baseline condition at 8 kHz and 51 dB SPL for 
example), but in healthy cochleae P0 was directly attributable to distinguishable in a subset of 
frequencies and well-supra-threshold stimulus levels. However, it is not only because of high 
stimulus levels since P0 did not appear with a 4 kHz stimulus even when the stimulus level was 
high ~ 100 dB SPL. Another observation of the response to the 4 kHz stimulus following perfusion 
was the development of a substantial response at the second harmonic, at 8 kHz. Since our method 
to cancel the CM in the CAP response (alternating polarity of stimulation) only works on the linear 
portion of the CM response, the 8 kHz component of the response is most certainly due to nonlinear 
distortion in CM at this high stimulus level, producing a pronounced second harmonic. 
Nonlinearity is also apparent in a DC shift of the response, in which the entire response waveform 




Figure 4.6 Example of CAP waveform change in response to a 4 kHz stimulus (animal: expt523). The gray 
shadow indicates the stimulus envelope. (The magnitude of the envelope does not reflect the stimulus level.) 
The dashed lines in conditions of “baseline” and “after 0.5% HA perfusion” indicate the first peak latency at 
the largest stimulus level. After 0.5% HA perfusion, substantial waveform changes occurred; in particular, the 
CAP response began with a large, short latency P0 instead of N1. The CAP response waveform partially 
recovered over time after the 0.125% HA and 0.25% HA perfusions. The rippled response that appeared first 
after the 0.125% perfusion at high stimulus levels is at 8 kHz (second harmonic of 4kHz), and this and the DC 




Figure 4.7 Example of CAP waveform changes in response to an 8 kHz stimulus (animal: expt523). The gray 
shadow indicates the stimulus envelope. After 0.5% HA perfusion, the CAP response was disto rted and started 
with a large, short-latency P0. A small P0 appeared at high stimulus levels even in the baseline condition. CM 
second harmonic is not apparent but could be present, as it would have been substantially attenuated by the 
CAP amplifier filter. 
4.3.3 Viscous fluid perfusion tore Reissner's membrane 
The changes in CAP waveform were only significant after perfusion of relatively high 
concentration HA, and may be due to the presence of viscous fluid in the cochlea or to trauma 
within the cochlea, or both. The presence of trauma is supported by the further results presented 
below.   
For the next step we investigated the cause of CAP threshold elevation presented in section 
3.1. HA is known to be nontoxic to the cochlea (103) and therefore physical explanations were 
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investigated. Since perfusate with the higher viscosity elevated the CAP thresholds more, two 
hypotheses were considered: 1. The increased viscosity of the cochlear fluid reduced the motions 
of the OC, leading to elevated thresholds; 2. Permanent damage of the cochlea occurred during 
cochlea perfusion. For the first hypothesis, the perfusion fluid was hypothesized to remain within 
the cochlea, damping the mechanical responses and thus affecting the hearing. In this case, the 
CAP thresholds would recover after replacing the viscous HA fluid with AP. For the second 
hypothesis, perfusion with high viscosity HA introduced shear stress that was sufficient to tear the 
RM or OC. In this case, the CAP thresholds would not recover after AP perfusion. 
 
Figure 4.8 CAP thresholds of HA cochlear perfusion followed by AP perfusion. The CAP thresholds were 
measured pre-perfusion, just after 0.125% HA perfusion, 20 min later, and just after AP perfusion. The 
thresholds improved 20 min after HA perfusion, and did not recover further after AP perfusion.  
To test hypothesis 1, responses with HA perfusion followed by AP perfusion were 
investigated. Experiments started with a 10 min 2.4 μL/min 0.125% HA perfusion, then a 20 min 
wait time, followed by a 10 min 2.4 μL/min AP perfusion. Results are in Figure 4.8. CAP 
thresholds were elevated after the 0.125% HA perfusion and recovered slightly after 20 min, 
confirming the result in Figure 4.4. However, after the AP perfusion, the thresholds did not recover 
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further. This result points to the second hypothesis, that CAP thresholds were elevated because of 
trauma induced by shear stress within the cochlear duct. 
 
Figure 4.9 Histological photo for perfused and control cochlea. Corresponding physiological data was in  
Figure 4.5. A: 0.0625% HA perfused cochlea. RM was intact. B: 0.125% HA perfused cochlea.  RM was partly 
torn (circled in red). C: 0.25% HA perfused cochlea. RM was partly torn (circled in red). D: Control. The RM 
was intact. Some parts of the OC were distorted because of the histological processing.  
To further explore this hypothesis, we histologically evaluated cochleae perfused with 
0.0625% HA, 0.125% HA and 0.25% HA. Because of the histological processing, some parts of 
the OC were distorted, such as the pillar cells and tectorial membrane (148). However, as shown 
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in Figure 4.9, RM was partly torn after 0.125% and 0.25% HA (Figure 4.9 B and C), while the 
RM after 0.0625% HA perfusion (Figure 4.9 A) and in a control cochlea (Figure 4.9 D) was intact. 
The result of the control cochlea and the one perfused with 0.0625% HA confirms that the 
histological processing and repeated cochlear perfusions did not cause the RM rupture. Considered 
along with the physiological data from the same cochleae in Figure 4.5, the observations of broken 
RM and CAP threshold elevation are correlated - the RM was only found to be broken in those 
cases when CAP thresholds were elevated. These results support the hypothesis that permanent 
damage of the cochlea occurred because of the shear stress produced during cochlea perfusion. 
The stress scales with the viscosity and larger stresses are likely responsible for the observation 
that the 0.5% HA perfusion resulted in larger and permanent CAP threshold elevations compared 
to perfusion with the lower dilution HA. 
4.4 Discussion 
4.4.1 Estimation of shear stress and pressure drop 
The present study provides results of cochlear perfusion with viscous fluid of various 
viscosities. The shear stress and pressure drops produced during the perfusion were calculated 
using the formulae introduced in Section 4.2.3 and results are shown in Table 4.1. Pure perilymph 
(AP) is also considered here for reference, and is taken to have a viscosity similar to that of water, 
0.001 Pas (27). The viscosities for HA solution with different concentration were estimated from 
(145). 
According to our results the cochlea can sustain the shear stress produced by 0.0625% HA 
at 25°C without significant damage. This would produce a shear stress up to 1.5 Pa, which is a 
factor of ~ 50 larger than the shear stress produced by AP perfusion. Shear stresses of 2.8 and 9.2 
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Pa, produced by the 0.125% and 0.25% HA perfusions respectively, resulted in a moderate hearing 
loss, based on the CAP threshold shifts observed in Figure 4.3–5. The 15.3 Pa shear stress produced 
by 0.5% HA perfusion is a factor ~ 510 larger than AP perfusion and resulted in a severe hearing 
loss. 
The final column in the table is an estimation of the pressure drop across the whole cochlea 
between the basal SV and the RW, due to the perfusion. It provides a tool for determining the static 








0% (AP) 0.001 0.03 3.9 
0.0625% 0.05 1.5 195 
0.125% 0.09 2.8 351 
0.25% 0.3 9.2 1169 
0.5% 0.5 15.3 1949 
Table 4.1 Estimation of the maximal shear stress on the cochlear wall and the pressure drop between the RW 
and the basal SV generated during the cochlear perfusion. The cochlea was treated as an uncoiled tube and 
the shear rate on the cochlear wall was 31.3 s -1 (see text). HA is assumed to have a constant viscosity at each 
concentration. 
4.4.2 Estimation of perturbation to cochlear mechanics due to viscous fluid 
When a more viscous fluid replaces the perilymph, BM motion may be affected because 
of the change in viscous forces. We did a study to determine when viscous forces are likely to 
become dominant in cochlear mechanics by comparing the size of terms in the Navier-Stokes 
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− 𝜌𝑣 ∙ ∇𝑣 + 𝜇∇2𝑣 
(4.4) 
ρ is fluid density, assumed that of water, 103 kg/m3. v is the fluid velocity (m/s). The sizes 
of the terms in the Navier-Stokes equation that involve fluid velocity can be estimated using 
dimensional analysis. Define L and U, scale factors used to characterize the fluid system. L is the 
extent over which fluid velocities vary by a factor of ~ e. Measured close and perpendicular to the 
BM, this was found to be ~ 15 m, independent of stimulus level and frequency (149). The 
theoretically predicted value is reasonably similar to this: Yoon et al. (150) show a decrease in 
slow-wave pressure of a factor of ~ 4 over an extent of 50 m, perpendicular to the BM. 15 m 
(the worse-case value for the purposes of the calculation here) is used for L in Table 4.2. U is scale 
factor of BM velocity, and depends on frequency and stimulus level. In a recent study (41), at the 
24 kHz best frequency the velocity amplitude, U, was ~ 0.5 mm/s at 30 dB SPL and ~ 3 mm/s at 
80 dB SPL. At 5 kHz it was ~ 2 μm/s at 30 dB SPL and ~ 0.6 mm/s at 80 dB SPL. μ is the viscosity 
of the cochlear fluid, .001 Pas for AP. As noted above, the viscosity of HA varies with shear rate; 
it is smaller at larger shear rates. Using shear rates calculated as 0.5U/L, the corresponding fluid 
viscosities were found from Maleki et al. (145) at 37 °C. The viscosity values are noted in Table 
2 for HA concentrations of 0.125% and 0.5%. In Table 4.2we compare the estimated sizes of the 
three terms in the Navier Stokes equation that depend on fluid velocity. The three are labeled the 



















AP 0.125% HA 0.5% HA 
24kHz 30dB 7.5×104 17 2.2×103 (𝜇 = 0.001) 1.6×105 (𝜇 = 0.07) 1.6×106 (𝜇 = 0.70) 
24kHz 80dB 4.5×105 600 1.3×104 (𝜇 = 0.001) 4.7×105 (𝜇 = 0.04) 3.3×106 (𝜇 = 0.25) 
5kHz 30dB 63 3×10-4 8.9×100 (𝜇 = 0.001) 4.4×103 (𝜇 = 0.50) 2.7×104 (𝜇 = 3.00) 
5kHz 80dB 1.9×104 24 2.7×103 (𝜇 = 0.001) 1.9×105 (𝜇 = 0.07) 1.9×106 (𝜇 = 0.70) 
Table 4.2 Comparison of terms in the Navier-Strokes equation. The units for all the terms is Pa/m. μ value is 
as noted, and with the unit Pas. ρ = 103 kg/m3, L = 15 m, U = 0.5 mm/s at 24 kHz and 30 dB SPL, 3 mm/s at 
24 kHz and 80 dB SPL, 2 μm/s at 5 kHz and 30 dB SPL and 0.6 mm/s at 5 kHz and 80 dB SPL. See text for 
further explanation. 
The nonlinear (second) term is much smaller than the other terms in all entries. It does not 
depend on viscosity and it is negligible throughout this analysis. The inertial (first) and viscous 
(third) terms are more similar in size. When the cochlea is filled with perilymph the inertial term 
is larger than the viscous term by a factor of 34 at 24 kHz and a factor of 7 at 5 kHz. For the 0.125% 
HA concentration the viscous term is larger than the inertial term by a factor of ~ 2 at 24 kHz, 30 
dB SPL, and the terms are ~ equal at 25 kHz, 80 dB SPL. At 5 kHz, 30 dB SPL the viscous term 
is larger than the inertial term by a factor of 70 and by a factor of 10 at 80 dB SPL. Thus, with the 
0.125% concentration of HA, viscous forces are expected to play a much larger role in cochlear 
mechanics. The U and L values above were taken from measurements in a normal cochlea, and 
due to the increased viscosity, U will decrease, but this affects the inertial and viscous terms 
similarly so does not affect their relative size. L, the distance over which the fluid velocity changes, 
is likely to increase in a more viscous fluid and this would mitigate the effect of viscosity, since 
that term is proportional to 1/L2. It is notable that we do not perfuse SM, so that side of the OC is 
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not affected by the high viscosity perfusions, and that will reduce the effect of viscosity. Viscosity 
of endolymph and perilymph have been reported as similar (151). Thus, with the 0.125 % HA, the 
inertial and viscous terms are likely both significant. With an increase to 0.5% HA, the viscous 
term is much larger than the inertial term and cochlear mechanics is expected to be dominated by 
viscous forces, which would eliminate the traveling wave.  
Based on our result, the cochlear sensitivity remains normal when its perilymphatic space 
is filled with < 50 times more viscous fluid (Table 4.1). Some aspects of this result were predicted 
by the models of Prodanovic et al. (152) and Sasmal and Grosh (153), in which increasing fluid 
viscosity by 10 fold had minimal effect on the BM gain in the cochlear base. However, both models 
predicted that the effect of fluid viscosity is greater in the apical regions (low frequencies), while 
our data did not indicate these apical/basal differences (Figure 4.3 C and D). 
4.4.3 Possible explanation for Temporary threshold shift (TTS) 
During the experiment, TTS were found after 0.125% and 0.25% HA perfusions. It is 
possible that the viscous fluid affecting the traveling-wave pattern contributed to the TTS. As 
discussed in section 4.2, the viscous term is significant with 0.125% HA. The viscous fluid might 
be naturally removed due to perilymph flow, and replaced by perilymph, which would return the 
cochlea to a more normal state. Salt et al. (19, 20) explored natural flow in the cochlea and reported 
that the clearance of trimethylphenylammonium (TMPA) from ST ranged from 20 min to 70 min 
depending on the turn of the cochlea where TMPA had been injected. These times are in the range 
of the times needed for TTS to stabilize in our study. It may require less time to clear the TMPA 
in their work since only 50 nL TMPA was injected into a small cochleostomy. On the other hand, 
since in our experiment the RW was torn, the perilymph flow rate should be higher as a result of 
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cerebrospinal fluid pressure (154), thus less time would be needed to remove the HA. Therefore, 
it is reasonable to consider that the clearance times of our study would be comparable to those of 
Salt et al. 
Another possibility is a temporary position shift of RM and OC. In Flock and Flock (155), 
static pressure caused hydrops and reduction of CM. Several studies found CAP threshold 
elevation under SM hydrops (103, 156). In the experiment of Salt et al. (103), SM, CM, CAP and 
EP were measured while pressurizing the cochlea with a slow injection of viscous 1% HA into the 
apex (1 μL max, at a rate of 0.1 μL/min). All these quantities were affected by the injection and 
all returned to normal essentially immediately when the injection stopped. This is different from 
our results in which the perfusion-induced changes in CAP persisted. It is possible that our 
experiment caused a long-lasting displacement of RM and OC and thus a longer lasting TTS, with 
partial recovery. However, due to the torn RM that we observed histologically, permanent damage 
occurred following full cochlear perfusions with HA of concentration 0.125% and above. 
4.4.4 The CAP waveforms 
In Figure 4.6 and 7 show that a significant CAP waveform change occurred after 0.5% HA 
perfusion. One substantial change is the appearance of the short latency P0. Figure 4.6 shows that 
in the normal cochlea the latency of P1 decreased as stimulus level increased. In results from a 
normal cochlea, a stimulus level increase from 35 to 95 dB SPL reduced P1 latency by ~ 0.72 ms. 
The P1 at 36 dB SPL in Figure 4.6 occurred at ~ 4 ms, so at 95 dB SPL P1 would be at ~ 3.28 ms, 
which is much later than the latency of P0 in Figure 4.6. Therefore, P0 is qualitatively different 
than P1, and seems to be a different response. It is notable that a P0 did not appear in a healthy 
cochlear response to the same frequency (4 kHz) even when the stimulus level was high, ~ 100 
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dB, but sometimes was present at some frequencies as a small peak (Figure 4.7). Below we give 
some speculative explanations for P0. 
One possibility is that the viscous 0.5% HA fluid caused the cochlea’s mechanical response 
to by dominated by a fast-mode instead of the normal slow traveling-wave mode (32, 117). Fast-
mode operation would reduce the latency of the CAP response and account for the short latency 
of P0. Indeed, the dimensional analysis of section 4.2 showed the dominance of viscous over 
inertial forces. This would severely damp the traveling-wave mode, which is based on the 
dominance of inertial fluid forces.  
Antoli-Candela and Kiang (157) found a similar P0 peak when they measured the CAP 
response to a click stimulus, and they ascribed it to CM. In our experiments, distorted CM could 
be seen in some responses as a second harmonic disturbance and a DC offset (Figure 4.6) and it is 
evident that nonlinearity in the mechanoelectric transduction that gives rise to CM has become 
exaggerated by the perfusion. It is possible that P0 is primarily produced by a combination of CAP 
response and SP. As mentioned in Section 4.4.3, Flock and Flock (155) found that static pressure 
caused a temporary hydrops of SM, and several studies have shown that hydrops of SM can result 
in increased SP (158, 159). Salt et al. (103) found that apical injections of viscous HA resulted in 
increased CM distortion and increased SP, and attributed the observations to a mechanically 
induced change in transducer operating point. Overall, we suspect that the short latency P0 is based 
in a combination of increased CM nonlinear distortion, with the presence of viscous fluid 
contributing to the short-latency. 
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4.4.5 Possible effects of torn RM 
In our histological studies, even 0.125% HA perfusion could cause tearing of the RM, 
which is expected to impair cochlear function. Although it was not measured, EP would drop and 
EP is necessary for normal cochlear function (51, 70, 160). In addition, it is possible that the 
endolymph and perilymph would mix. We withdrew the fluid from the SV, which might have 
caused a slightly negative pressure in SV compared to SM, causing endolymph to flow from the 
SM into the SV. Notably, endolymph would have flown into SV, and not directly into ST. Tasaki 
et al. (14) showed that endolymph in ST greatly depressed CM and auditory nerve responses, likely 
due to the high extracellular K+ leading to hair cell depolarization and damage. In our study, the 
endolymph would flow from the RM opening to SV but would not then flow to the ST because the 
perfusion fluid went from ST to SV. Previous studies have indicated that connections between 
endolymph and perilymph can lead to localized impairment. For example, Suga et al. (161) showed 
that EP in the basal turn was not affected by destruction of the more apical turns, and vice-versa. 
These findings are in accord with our results that the 0.125% and 0.25% perfusions of Figure 4.5 
and 9 did not elevate CAP thresholds drastically even though they resulted in a torn RM. 
4.5 Conclusion 
The physiological and anatomical effects of perfusing the cochlea with a viscous fluid were 
studied. With increasing concentrations, and thus increasing viscosity of HA, the CAP thresholds 
increased. The cochlea could sustain, without CAP threshold shift, a perfusion of up to 0.0625% 
HA at the rate of 2.4 μL/min, corresponding to a 1.5 Pa shear stress. 0.125% and 0.25% HA 
perfusion caused some hearing loss, and RM damage in the cases where histology was performed. 
The perfusion of HA at higher concentrations produced sufficient shear stress to cause large 
threshold shifts, which could partially recover. The recovery may be because of the natural clearing 
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of viscous fluid from the perilymphatic space, or because of a temporary shift in the position of 
the OC. The perfusion of the highest concentration HA we used (0.5%) occurred with a CAP 
waveform change in which a short latency positive peak P0 appeared, which is suspected to be due 
to a combination of fast-mode domination of cochlear mechanics and increased CM nonlinear 
distortion due to transducer operating point changes. 
The shear stress and pressure drop of cochlear perfusion with fluid of different viscosities 
were estimated. This provides a useful standard for considering what viscosities and flow rates are 
likely to be safe in cochlear perfusions.  
This study was motivated by findings in which 0.5% HA solution was used in a novel 
perfusion-implantation technique. Although the technique was successful in achieving deep 
cochlear implantations without the implant penetrating the cochlear partition, it led to substantial 
threshold elevation. Based on our findings, 0.0625% HA is safe for 2.4 μL/min perfusions in the 
gerbil. In humans, with substantially wider scalae, these numbers can be considered lower limits. 
For the future development of the perfusion-implantation concept, in order for 0.0625% HA to be 
successful in guiding a cochlear implant, very compliant implants will be required, and perhaps a 






Chapter 5 Cochlear amplification and the 
chloride sensing function of prestin 
5.1 Introduction 
The motor protein for OHC, prestin, was first identified by Zheng et al. (86) . It is a 
modified chloride transporter that requires Cl- binding to enable its electromotility (87). Recent in 
vitro studies showed that the NLC of OHC can be influenced by modifying the 
extracellular/intracellular Cl- concentration (21, 162-164). Surprisingly, (21) showed that the 
amplitude of BM motion can be influenced by increasing extracellular Cl- in vivo, or even 
improved in a slightly damaged cochlea. Those in vivo/vitro studies used tributyltin (TBT), a 
chloride ionophore, to manipulate intracellular chloride concentration. It is the only in vivo 
manipulation that has been found (other than positive DC electric current) that can improve BM 
motion in a damaged cochlea. However, the side-effects of increasing intracellular Cl- 
concentration should be carefully examined, for example, increasing intracellular Cl- concentration 
can result in OHC swelling (21). This change in shape might affect the operating point of 
mechanoelectric transduction, which would affect cochlear nonlinearity and result in a waveform 
distortion, and these possibilities merited exploration. 
To further explore the effect of intracellular Cl- concentration, we monitored cochlear 
sensitivity and nonlinearity while manipulating Cl- concentration using cochlear perfusion. This 
would examine the possibility of increasing intracellular Cl- concentration as a method for boosting 
hearing sensitivity. These experiments did not work as we hoped, but information was gained from 
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the results nevertheless. These results were not reported due to lack of a complete story, but it is 
useful to have them documented for future work. 
5.2 Experimental Design 
The basic idea is to test for changes in OHC activity due to increasing intracellular Cl- 
concentration, in both normal and less sensitive cochleae. Gerbils with normal CAP thresholds 
were used. To modify the extracellular/intracellular Cl- concentration of OHC soma while keeping 
the endolymph bathing the stereocilia unchanged, local perfusion in the basolateral side, i.e. ST, 
was applied near the basal region of gerbil cochleae. An ~ 200 μm diameter hole was made in ST 
at the basal turn (Figure 5.1), and the RWM was torn. The ST hole was plugged with cochlear 
perfusion cannula with its tip glued in place. A forward perfusion method was used. The fluid 
entered ST through the ST hole, and flowed out from RW, thus perfusing the basal ST region. The 
BF of this location is > 12 kHz. 
 
Figure 5.1 Diagram of localized cochlear perfusion. The perfusate was injected via cochleostomy in ST, 
flowed out from opened RW. 
For each perfusion, a 10 min perfusion with a rate of 2.0 μl/min was used. Three kinds of 
perfusate are expected to reduce cochlear sensitivity: 1. low Cl- concentration (8.5 mM, 
97 
 
substitution with gluconate) AP, to decrease extracellular Cl- concentration; 2. low Cl- 
concentration (8.5 mM) AP with 50  a chloride ionophore that enables chloride ions to 
flow down their intracelluar:extracellular concentration gradient, to decrease intracellular Cl- 
concentration; 3. Salicylate (1 mM), an ototoxicant that competes with Cl- to bind with prestin. AP 
with normal Cl- concentration (133.5 mM) was used as control. The combination of normal AP 
with 50  is expected to increase the intracellular Cl- concentration, which is ~ 10 mM in 
the healthy guinea pig (21). The osmolality of the perfusate was adjusted to be the same as 
normotonic perilymph, 300 mOsM, with glucose (evaluated using Freezing Point Osmometer, 
Advanced Instruments, Norwood, MA). After each perfusion, CAP and DPOAE (f2 = 1.2f1, equal 
SPLs) were measured to monitor cochlear condition (see Section 2.3 and 2.4 for methods) via 
auditory nerve response and cochlear nonlinearity. 
5.3 Results and Conclusion 
The first step was to repeat the experiments done on guinea pig by Santos-Sacchi et al. (21). 
In their experiment, by measuring the BM motion as the indicator of cochlear amplification, they 
did a series of in vivo tests to study Cl- modulation of cochlear amplification. Their observations 
were: 1. In a surgery-induced less-sensitive cochlea, increasing intracellular [Cl-] (AP+TBT 
perfusion) increased BM motion; 2. Decreasing extracellular Cl- concentration (LowCl+AP 
perfusion) reversibly reduced BM motion. After the wash out and recovery, increasing intracellular 
[Cl-] (AP+TBT perfusion) further increased BM motion to a level even larger than the initial value. 
Yet this decrease of BM motion could not be countered by the LowCl+TBT perfusion. 3. Salicylate 




Figure 5.2 CAP thresholds after perfusion of different fluids. Each figure corresponds to an individual gerbil, 
with the noted series of perfusion fluids (expt615, 616 and 617). Low Cl - AP has no significant effect on CAP 
thresholds. Perfusion with AP+TBT worsen the CAP thresholds in salicylate damaged cochlea. 
In our experiments, CAP thresholds and DPOAE were measured to test hearing sensitivity 
as relatively simple methods to determine if we could repeat the results of Santos-Sacchi et al. 
Theoretically, a higher BM motion results in lower CAP threshold and higher DPOAE amplitude. 
Figure 5.2 shows our CAP results of three different animals with different perfusates applied 
sequentially. As expected, only frequencies higher than 10 kHz were affected. However, we were 
unable to improve the responses, as Santos-Sacchi et al. had: 1. In preparations with slight surgery-
induced damaged cochlea, AP+TBT perfusion did not show any improvement of CAP thresholds 
(data not shown); 2. In the two animals shown in Figure 5.2 A&B, we were not able to reduce 
cochlear responses by reducing extracellular [Cl-], using low Cl-+AP perfusion as Santos-Sacchi 
et al. did, as the result shows no significant effect on either CAP thresholds (Figure 5.2 A&B) or 
DPOAE responses (Figure 5.3).  Low Cl-+TBT perfusion was used to reduce intracellular [Cl-]. 
This method successfully worsened the CAP thresholds at high frequencies > 10 kHz, but the 
effect could not be reversed by either AP+TBT perfusion or AP flushing; 3. In the animal shown 
in Figure 5.2 C, salicylate perfusion worsened the CAP thresholds, and was reversible to some 




extent with AP flushing as expected. But AP+TBT perfusion did not help the recovery, and even 
worsened it.  
 
Figure 5.3 DPOAE (f2 = 1.2f1, equal SPLs) variation after perfusion of different fluids (expt615, same animal 
as Figure 5.2 A). Perfusion with low Cl - AP has no significant effect on DPOAE amplitudes. 
According to our observation, CAP thresholds were elevated after all TBT perfusions, 
regardless of the perfusate Cl- level. The difference with the results of Santos-Sacchi may simply 
be because of the different species. Alternatively, the difference might have been due to our 
different evaluation methods. BM motion measurement and CAP thresholds can both reflect the 
cochlear condition. Yet BM motion is rather a direct measurement of intracochlear mechanics, 
while CAP thresholds evaluate cochlear sensitivity by the auditory nerve response. TBT has been 
reported to have neurotoxicity in nM level (165, 166). It is possible that the elevation of CAP 
thresholds after TBT perfusion was because of auditory nerve damage regardless of how BM 
motion changed.  Fortunately, the DPOAE result removes this ambiguity. The DPOAE 
measurements, which reflect cochlear nonlinearity, indicate that the CAP elevation with TBT 
perfusion cannot be simply explained by auditory nerve damage (Figure 5.4). The DPOAE 
reduction of salicylate-damaged cochlea was unable to be improved by later AP+TBT perfusion. 
Instead, DPOAE amplitudes decreased after AP+TBT perfusion, showing that TBT perfusion 




Figure 5.4 DPOAE (f2 = 1.2f1, equal SPLs) variation after perfusion of different fluids (expt617, same animal 
with Figure 5.2 C). Salicylate perfusion mildly decrease DPOAE, but the reduction was reversible after AP 
washing. Perfusion with AP+TBT cannot improve DPOAE amplitude in salicylate damaged cochlea, but 
worsen it. 
Santos-Sacchi et al. (21) showed that using TBT to increase intracellular Cl- concentration 
can counter the NLC reduction blocked by salicylate in vivo and in vitro. While under the in vitro 
condition, it is known that extracellular chloride manipulation can modulate OHC turgor and 
membrane tension (163, 167), which had been shown to shift the OHC NLC curve (168-170). 
These mechanisms may contribute to their findings. Therefore, the increased BM velocity in vivo 
may be explained in another way: along with countering the NLC reduction, increasing 
intracellular Cl- concentration could have optimized the center voltage Vm of the peak capacitance 
in the NLC curve. This process of optimization may be fine-tuned and not repeatable in another 
animal. Over all, our experiments showed that using TBT to increase intracellular chloride 
concentration is not a reliable method to boost cochlear amplifier in vivo, due to the neurotoxicity 
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of TBT and the side effects associated with increasing intracellular chloride concentration.  






Chapter 6 Summary 
Sound waves strike the eardrum and are delivered into the inner ear, driving the fluid in 
the three cochlear compartments. The fluid surrounding the BM sets a traveling wave along the 
cochlea. The traveling wave peaks at a specific resonant region due to the inertia of the fluid and 
the varied mechanical properties along the BM. Cochlear amplification locally enhances the 
vibration in the best frequency peak by factors of hundreds to boost the frequency selectivity and 
sensitivity of the cochlea. This thesis aimed to understand the cochlear tuning and investigate 
possibilities to manipulate the cochlear amplifier, by testing the cochlear amplifier’s sensitivity to 
different operating conditions.  
In Chapter 3, we tested whether a high EP is necessary for a moderate degree of cochlear 
amplification. With IV furosemide injection to reversibly reduce EP, the cochlear amplification 
observed in LCM could attain nearly full or even full recovery with ~ 20 mV reduced EP. Thus, 
the cochlea has an ability to adjust to diminished operating condition. Next, the mechanism of this 
adjustment was investigated. We observed that the cochlear amplification just started to recover 
after the EP was nearly fully recovered and stabilized. Using a Boltzmann model and the 2nd 
harmonic of the LCM to estimate the transducer OP, we showed that this non-simultaneous 
recovery of cochlear amplification happened along with a shift in the OP. These observations 
suggest that cochlear amplification is capable of adjusting to lower EP by optimizing the OP of 
the MET transducer current.  
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In Chapter 4, we tested whether the fluid viscosity in the perilymphatic space is a crucial 
factor for cochlear sensitivity. The data indicated that the cochlear sensitivity (measured by CAP 
threshold) remained normal with higher fluid viscosity (due to perfusion with HA) up to a factor 
of 50, showing that the fluid viscosity in the perilymphatic space is not a primary factor for 
cochlear mechanics. The physiological and anatomical effects of perfusing the cochlea with a 
viscous fluid was also tested. The cochlea could sustain, without CAP threshold shift, a perfusion 
of up to 0.0625% HA at the rate of 2.4 μL/min, corresponding to a 1.5 Pa shear stress. The 
perfusion with higher viscosities caused hearing loss, and RM damage in the cases where histology 
was performed. The shear stress and pressure drop of cochlear perfusion with fluid of different 
viscosities were estimated. This provides a useful standard for considering what viscosities and 
flow rates are likely to be safe in cochlear perfusions.  
In Chapter 5, we tested the possibility of using TBT to increase intracellular Cl- 
concentration to boost cochlear amplification. Our experiments showed that using TBT to increase 
intracellular chloride concentration is not a reliable method to boost cochlear amplifier in vivo, due 
to the neurotoxicity of TBT and the side effects associated with increasing intracellular chloride 
concentration. 
In this thesis we showed that cochlear amplification is capable of adjusting to modified 
cochlear operating conditions. However, the mechanism of the adjustment is yet to be explored. 
For future direction, several other things can be done: 
1. We showed the cochlear amplification can be adjusted to low EP by optimizing OHC 
MET channel operating point. The relatively slow recovery of this optimizing process (hours) 
indicates it is not a known adaptation mechanism of MET ion channels, which occur over time 
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scales of less than 1 s. The recovery might also hinge on the recovery of proper ionic concentrations 
and OHC resting potential, required for prestin to return to a functional state. Change in 
endolymphatic ion concentrations (e.g. K+, Ca2+ and Cl-) may contribute to the adaptation of 
cochlear amplification. These factors needed to be considered in future work. 
2. We showed that the OHC transduction current achieved nearly a full recovery in low EP, 
which is not consistent with the CAP measurement, which did not recover fully. The relationship 
between EP change and CAP threshold was found to have a slope close to -1.0 dB/mV. This 
difference in recovery of OHC transduction current and CAP response may be due to a decrease 
of transduction current in IHC, which governs the neuron signal that CAP measures. Another 
possibility is the OHC electromotility failed to generate a proper feedback to the mechanical 
response at the BM. This feedback links to the HB deflection in IHC. To test this possibility, the 
change in mechanical response with furosemide-induced low EP needs to be measured. An OCT 
system, which is able to detect the motion in BM and TM simultaneously, is a great tool to address 
this problem. 
3. In this thesis, the recovery of cochlear amplification with low EP was shown in an animal 
model with drug-manipulated EP. In aged animals, the situation may be different. It is known that 
animals with presbycusis have poor hearing sensitivity and decreased DPOAE, but it is unknown 
whether the cochlear amplification optimizing process we found occurs during the development 
of age-related hearing loss. Testing this question links our finding with a realistic clinical problem. 




4. We showed that fluid viscosity in the perilymphatic space is not a primary factor for the 
sensitivity of the auditory system, using CAP threshold as an indicator. The threshold represents 
the cochlear sensitivity to low-to-moderate sound level, and the response for a fuller dynamic range 
needs further exploration. Besides, our finding about the temporary thresholds shift in CAP 
threshold, and P0 in CAP waveform needs further exploration, by measuring the electrical or 
mechanical response of the OHC or BM.  
5. We found that for cochlear perfusion, 0.0625% HA is safe for 2.4 μL/min perfusions in 
the gerbil. For the future development of the perfusion-based implantation method, in order for 
0.0625% HA to be successful in guiding a cochlear implant, very compliant implants will be 
required, and perhaps a surface treatment to make them more fully coupled to the only moderately 
viscous perfusion fluid. These remaining issues can be addressed in the future work. 
With the finding of this work, we concluded that the cochlea is more robust than what we 
previously believed – the cochlear amplification is capable of re-adjusting to a variety of operating 
condition changes. We hope that with these new discoveries, as well as what is to be explored as 
a continuation of this work, we could expand our knowledge on hearing mechanism. With a deeper 
understanding, innovative and more affordable solutions to hearing loss restoration is possible 
through the help of the cochlea’s intrinsic adapting ability. And such remedies will improve the 
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